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Abstract

NON-MEDICAL USE OF PRESCRIPTION STIMULANTS FOR WEIGHT LOSS:
PREDICTORS, CONSEQUENCES, AND IMPLICATIONS FOR INTERVENTION IN A
NATIONAL YOUNG ADULT SAMPLE
By: Amy J. Jeffers, M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2016.
Major Director: Eric G. Benotsch, Ph.D.
Associate Professor of Psychology
Director, Health Psychology
Department of Psychology
The non-medical use of prescription drugs is an important public health concern.
Non-medical use of prescription stimulants (NMUPS), specifically medications used to treat
Attention Deficit Hyperactivity Disorder (ADHD), is particularly concerning. One timely
concern regarding NMUPS, especially among young adults, is their role in appetite
suppression/weight loss. Indeed, some individuals are motivated to misuse such drugs for the
purpose of losing weight. Engaging in NMUPS for weight loss has been examined only
minimally in the research literature. However, extant data demonstrate that this behavior is
associated with other unhealthy behaviors and poor psychosocial health. Limitations of prior
	
  

	
  
research include the exclusive use of college student samples and little attention to relevant
health behavior theory. The current study investigated NMUPS for weight loss in a national,
young adult sample (n = 1526), ages 18-25 years, utilizing Amazon’s Mechanical Turk.
Motivations and attitudes about NMUPS were evaluated, within the framework of the Theory
of Planned Behavior (TPB). A structural equation model (SEM) was analyzed, which
included attitudes; social norms; and perceived behavioral control (PBC) to lose weight
without stimulants, as predictors of engaging in past year NMUPS for weight loss.
Approximately 12.0% of participants reported lifetime NMUPS for weight loss, and of these,
48.4% reported past year use. Findings demonstrate that use is related to disordered eating
and unhealthy weight loss behaviors, including vomiting; high rates of other substance use;
and psychological concerns, including body dissatisfaction and depressive symptomatology.
These results suggest that NMUPS for weight loss is associated with a variety of negative
consequences and users are not well-informed regarding medication knowledge. The SEM
provided adequate overall fit to the data; two of the four social norms and both PBC factors
were significantly associated with NMUPS for weight loss. This study extends the literature
on the utility of the TPB in examining NMUPS, and provides the first research on utilizing
the TPB to examine NMUPS for weight loss. Methods aimed at increasing PBC regarding
stimulant use and weight loss, and emphasizing healthful and sustaining weight loss
strategies, improving mental health, and educating about polysubstance use are potential
intervention targets.

	
  

	
  
Non-medical use of prescription stimulants for weight loss: Predictors, consequences, and
implications for intervention in a national young adult sample
Non-medical Use of Prescription Drugs
In recent years, there has been a dramatic increase in the non-medical use of
prescription drugs (NMUPD), including the use of psychotropic or analgesic medications
(e.g., pain relievers, tranquilizers, sedatives, stimulants) without a physician’s prescription, as
well as the intentional misuse of one’s own medication among young adults. Consistent with
the definition used in the Substance Abuse and Mental Health Services Administration’s
(SAMHSA) National Survey on Drug Use and Health, “NMUPD” will be used in this paper
as the umbrella term to describe use without a prescription, as well as intentional misuse of
one’s own prescription (e.g., use too much, use to get high, or use to increase other drug or
alcohol effects; SAMHSA, 2012). Thus, this commonly used definition includes both those
who use prescription drugs without a doctor’s prescription and those who intentionally
misuse their own prescription drugs. However, when necessary, distinctions between nonmedical use versus intentional misuse will be made clear.
Motives for NMUPD include: to get high, for experimentation, to enhance energy,
relieve pain, and to lose weight (Jeffers & Benotsch, 2014; Jeffers, Benotsch, & Koester,
2013; McCabe & Cranford, 2012). In national studies, as many as 29.2% of young adults
(18-25) report NMUPD in their lifetime (Institute for Behavior and Health, n.d), with almost
6% reporting NMUPD in the past month (SAMHSA, 2012). In 2012, a young adult in the
United States (U.S.) was more likely to use a prescription drug non-medically than to use any
illicit substance except marijuana (SAMHSA). NMUPD now accounts for more emergency
room (ER) visits than use of all illicit substances combined (SAMHSA, 2012). Data from
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other national samples have demonstrated that NMUPD is a risk factor for future drug
dependence (Schepis & Krishnan-Sarin, 2008), binge drinking (McCauley et al., 2011), and
substance use disorders (Schepis & Hakes, 2011). NMUPD has been associated with poor
mental health, including depressive symptoms, suicidality, and anxiety (Dussault & Weyandt,
2013; Zullig & Divin, 2012). NMUPD has also been related to sexual risk behavior,
including more sexual partners and unprotected sex (Benotsch, Koester, Luckman, Martin, &
Cejka, 2011).
Non-medical Use of Prescription Stimulants
One particularly concerning trend is the rise in the non-medical use of prescription
stimulants (NMUPS; Arria & DuPont, 2010; Rabiner et al., 2009). Lifetime prevalence rates
are estimated as high as 34% among college students (DeSantis, Webb, & Noar, 2008).
Motivations for NMUPS include: to help with concentration, to increase alertness, to get high,
and for the sake of experimenting (Teter, McCabe, LaGrange, Cranford, & Boyd, 2006).
NMUPS is associated with adverse health effects including increases in heart rate, blood
pressure, body temperature, and malnutrition due to a decrease in appetite (National Institute
on Drug Abuse [NIDA], 2009). Chronic stimulant use can lead to paranoia and hostility and
high doses can lead to cardiovascular consequences (NIDA, 2009). Mixing prescription
stimulants with drugs or alcohol can exacerbate these side effects (Higher Education Center,
2012). NMUPS has been associated with other substance use including use of alcohol,
tobacco, marijuana, cocaine, and ecstasy (Lanier & Farley, 2011). Indeed, NMUPS is
associated with past year alcohol or drug use disorders in both males and females (Wu,
Pilowsky, Schlenger, & Galvin, 2007). Further, between 2005 and 2010, the number of ER
visits related to NMUPS increased dramatically from 5,212 to 15,585 (SAMHSA, 2013).
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One timely concern regarding NMUPS, especially among young adults, is their role in
appetite suppression.
NMUPS for weight loss. Prescription stimulant medications used to treat Attention
Deficit Hyperactivity Disorder (ADHD), for example, Adderall and Ritalin, have shown
promise for improving the main symptoms of ADHD and enhancing academic performance
among those with ADHD (Zachor, Roberts, Hodgens, Isaacs, & Merrick, 2006). However, a
common side effect of these medications is appetite suppression (Zachor et al., 2006) and
subsequent weight loss (Kent, Blader, Koplewicz, Abikoff, & Foley, 1995). Because of this
widely known side effect of ADHD medications, and given the increasing number of young
adults who report a desire to lose weight (Neumark-Sztainer, Wall, Larson, Eisenberg, &
Loth, 2011), some individuals are motivated to misuse such drugs for the purpose of weight
loss (Jeffers & Benotsch, 2014; Jeffers et al., 2013). Further, there is a widespread
misperception that prescription drugs are safe even when taken without a prescription (NIDA,
2013). This misperception, and the ease of obtaining these substances, contribute to their
frequent non-medical use. Indeed, many individuals who share medications are unaware of
their dangers and procure them for free from a friend or relative (NIDA, 2013). Thus,
stimulant medication might seem like a cheap, easy way to lose weight. Engaging in the nonmedical use of prescription ADHD medication for the purpose of weight loss has been
discussed in the popular press, but has been examined only minimally in the research
literature, has rarely been a focal point of research, and has been examined exclusively in
college students (e.g., Jeffers & Benotsch, 2014; Jeffers et al., 2013; Rabiner et al., 2009;
Teter et al., 2006).
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In one study, the non-medical use of specific prescription stimulants was examined
along with the motives for such use in a random sample of college students (n = 4580; Teter
et al., 2006). About 9.7% (n = 37) of the lifetime users reported using stimulants not
prescribed to them for the purpose of weight loss. However, this motivation was the sixth
highest reason given after motives such as improving concentration, as a study aid, and
increasing alertness. The use of prescription stimulants for weight loss was minimally
examined in this study. Rabiner and colleagues (2009) examined the misuse of ADHD
medication among individuals who reported having a current prescription for these
medications (n = 115), of which 27 reported misuse. Motivations for misusing prescription
stimulants were discussed, including for the purpose of losing weight. However, this was not
a focal point of the research as this behavior was minimally endorsed within the sample.
Judson and Langdon (2009) found that 3.6% of individuals reported non-medically using
ADHD medication to lose weight in a sample of 333 students (both prescription and nonprescription holders). DeSantis and colleagues (2008) examined non-medical use of
prescription ADHD medications among college students and found that among the 585
participants that reported use without a prescription, 5% reported using for the purpose of
suppressing appetite. This motive was also mentioned in qualitative interviews the
researchers conducted. For some participants, appetite suppression was a beneficial side
effect to use, and for some it was the primary motive. For example, one participant who
reported studying as the main motive of NMUPS said, “It is kind of cool that you also don’t
want to eat either” (DeSantis et al., 2008). Another participant reported, “The first time I
used it was because one of my sorority sisters told me how great it was. She said you don’t
want to eat, and it is safe and everything” (DeSantis et al., 2008).
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NMUPS for weight loss as a focal point. To the PI’s knowledge, only two studies
have focused strictly on NMUPS for the purpose of weight loss (Jeffers & Benotsch, 2014;
Jeffers et al., 2013). In the first of these studies, 11.7% of young adults (n = 705) surveyed
reported having used a prescription stimulant for weight loss (Jeffers et al., 2013).
Individuals who reported using prescription stimulants for weight loss were more likely to
report dieting, had greater appearance-related motivations for weight loss, greater emotion
and stress-related eating, a more compromised appraisal of their ability to cope, lower selfesteem, and were more likely to report engaging in other unhealthy weight loss and eating
disordered behaviors such as vomiting, using laxatives, utilizing a fad diet, and skipping
meals. Indeed, these individuals were eight times more likely to engage in these behaviors.
However, a limitation of the Jeffers et al. (2013) study included not clearly
differentiating between those who misused their own ADHD medication from those who
received medication from another source. Thus, the researchers were unable to differentiate
between individuals who were misusing their own medication for the purpose of weight loss
(i.e., for a purpose other than was intended) versus those who were receiving medication
from others for the purpose of weight loss (i.e., non-medical use).
A follow-up investigation examined NMUPS for weight loss, recreational drug use,
disordered eating, and body image (Jeffers & Benotsch, 2014). This study examined young
adults’ (n = 707) NMUPS, in general and for weight loss, other recreational and illicit drug
use, perceived effectiveness of NMUPS for weight loss, eating disordered behaviors and
symptomatology, and body image. Current ADHD prescription holders were excluded from
this study because these medications are sometimes prescribed off-label for weight loss
(Bernstein, 2006; Johnson, 2006), and the researchers wanted to account for this possibility.
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Moreover, they wanted to focus the investigation on users who did not actually have a
prescription but were getting the medication from another source. Approximately 4.4% of the
sample engaged in NMUPS for weight loss. Individuals who engaged in NMUPS for weight
loss had problematic attitudes and feelings related to eating, including a high level of concern
regarding dieting and weight. These individuals also engaged in problematic eating behaviors
and had higher eating disorder symptomatology. Indeed, vomiting to control one’s weight
and shape, as well as laxative, diet pill, or diuretic use, were robustly associated with
NMUPS for weight loss. There was also an association with binge eating, but this relation
became nonsignificant when examined from a multivariate perspective. Individuals who
engaged in NMUPS for weight loss had lower body appreciation and higher body image
concerns, specifically related to the media. Individuals who used stimulants for weight loss
were also more likely to use other recreational drugs, including marijuana, cocaine,
methamphetamine, and hallucinogens.
Theory of Planned Behavior
One limitation of these prior studies is that they were largely atheoretical. Applying a
health behavior theory to a problematic behavior can provide a useful framework for better
understanding the constructs related to that behavior, which can aid in developing
interventions. The Theory of Planned Behavior (TPB; Ajzen, 1991; Ajzen, 2002) postulates
that intention to engage in a particular behavior is a result of personal attitudes toward the
behavior, social norms, and perceived behavioral control.
Within this model, attitudes refer to the degree to which a person has a positive or
negative evaluation or appraisal regarding a certain behavior, and encompass beliefs about
possible consequences or other attributes of the behavior. Social, or subjective norms, are
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perceived social pressures to engage or not to engage in a particular behavior, and concern
expectations of important others. Finally, perceived behavioral control refers to individuals’
perceptions of their ability to perform a specific behavior. Perceived behavioral control is
assumed to reflect both past experiences and future circumstances with respect to the
behavior. Both self-efficacy (i.e., perceived ability to perform a behavior) and controllability
(i.e., beliefs about whether performing the behavior is up to the individual) items should be
incorporated when measuring perceived behavioral control, although control can be treated
as a unitary factor depending on the purpose of the research (Ajzen, 2002). Taken together,
these three constructs form a behavioral intention. Intentions are believed to encompass the
motivational factors that influence a behavior, and, along with perceived behavioral control,
account for a large proportion of variance in actual behavior (Ajzen, 1991).
The TPB and examinations of health behaviors. The TPB has been shown to
predict various health-related behaviors, including exercise (Nguyen, Potvin, & Otis, 1997),
diet (Conner, Kirk, Cade, & Barrett, 2003), as well as addictive behaviors including binge
drinking (Collins & Carey, 2007), smoking (Van De Ven, Engels, Otten, & Van Den Eijnden,
2007), and illicit drug use (Morrison et al., 2010). For example, Collins and Carey (2007)
examined the TPB in relation to binge drinking in college students and found that drinking
refusal self-efficacy and attitudes predicted intention. Further, intention predicted Time 2
binge drinking. Van De Ven et al. (2007) found that smoking-related cognitions predicted the
onset of smoking via intention among adolescents with and without asthma. The TPB has
also been used to predict marijuana use among unmarried pregnant adolescents (Morrison et
al., 2010).
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TPB and NMUPD. The TPB has also been used to predict NMUPD, and NMUPS, in
particular. Judson and Langdon (2009) used the TPB to examine NMUPS in college students
(n = 333) with and without ADHD prescriptions. Participants were recruited from two New
England colleges and the sample was predominantly White (89%). Prescription holders and
non-prescription holders were compared on a variety of domains, including motives for use,
knowledge of medication side effects, and TPB constructs. NMUPS for non-prescription
holders was defined as using stimulant medication without a prescription. NMUPS for
prescription holders included using stimulant medications in excess or for purposes other
than intended (i.e., treating ADHD). Results were consistent with the TPB, particularly for
non-prescription holders, such that they had fewer concerns regarding adverse health effects
and ethics of use, higher perceived positive social norms, and lower perceived behavioral
control (i.e., felt more dependent on stimulant medications). Judson and Langdon (2009) did
not directly measure intention to use, but the relation between these beliefs and attitudes were
directly related to NMUPS. As previously mentioned, 3.6% of participants reported weight
loss as a motive for NMUPS. However, it is unclear whether this motive was endorsed by
prescription holders, non-prescription holders, or both. Moreover, the investigators did not
focus on this motivation in their study.
In a dissertation study, Gallucci (2011) created a survey instrument using TPB
constructs (including modified items from Judson and Langdon’s [2009] work) to examine
NMUPS and diversion behavior (e.g., selling medications, sharing among friends) among
undergraduates aged 18-24 (n = 1026). Gallucci did not directly measure intention to use, but
attitudes and perceived behavioral control were related to lifetime NMUPS, with the latter
being the strongest predictor of lifetime NMUPS; social norms, however, were not related.

8

	
  
Gallucci mentioned that the social norm variables (e.g., beliefs held by relevant others) were
associated with higher numbers of participants who had incomplete data. He posited that
participants’ unwillingness to answer these questions might be attributable to the survey
administration (e.g., close proximity to friends in the classroom during survey completion).
Only perceived behavioral control was related to recent non-medical use (i.e., past 30 days;
Gallucci, Martin, Beaujean, & Usdan, 2015). Findings indicate that some elements of the
TPB are related to lifetime NMUPS, and that the TPB has limited utility in predicting recent
NMUPS, at least for the past 30 days, in undergraduates ages 18-24.
In a master’s thesis, Srigley (2013) examined behavioral intentions to use prescription
stimulants, depressants, and opioids non-medically within the next year in a sample of 131
college students. Both attitude toward use and perceived behavioral control emerged as
strong predictors of intention to engage in NMUPD.
Finally, Ponnet and colleagues (Ponnet, Wouters, Walrave, Heirman, & Van Hal,
2015) examined Flemish college students’ (n = 3,589) intention to engage in NMUPS for the
purpose of enhancing academic performance. They used an extended model of the TPB and
found that subjective norms, followed by attitudes and perceived behavioral control predicted
intention to use, among other variables (e.g., substance abuse, procrastinating tendencies).
Overall, few studies have examined the TPB as it applies to NMUPS. The four
aforementioned studies have resulted in inconsistent results and warrant further research to
determine the ability of the TPB to predict NMUPS (e.g., Gallucci, 2011). Moreover, two of
the four studies involved small samples (e.g., 131 and 333) with the exclusive use of
undergraduate students.
NMUPS in College Students and Non-College Students
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The majority of studies examining NMUPS among young adults have focused on
college students, as prevalence rates of NMUPS are typically higher in this population
compared with their non-college peers (Herman-Stahl, Krebs, Kroutil, & Heller, 2007). This
is not surprising given the commonly reported motives for NMUPS related to improving
academic performance (Herman-Stahl et al., 2007). College students may also have greater
exposure to individuals using prescription medications (both for medical and non-medical
purposes; Herman-Stahl et al., 2007). However, NMUPS prevalence rates vary and range
from 3-36% (McCabe, Teter, & Boyd, 2006) in college student samples depending on
geographic location and school admission standards (Gallucci, 2011).
Relatively few studies have examined NMUPS in non-college populations (e.g.,
Herman-Stahl et al., 2007; Wu et al., 2007). Although there is evidence to support higher
prevalence rates in college populations, non-college young adults are also at risk for
engaging in this behavior. Kelly and colleagues (2013) found that in a sample of socially
active young adults who participate in urban nightlife (n = 1207), 44.1% reported lifetime
NMUPD, with NMUPS as the most prevalent in the past 6 months (16.7%). Although the
authors did not report on college attendance rates, it is highly probable that this community
sample consisted of both students and non-students. As the authors concluded, a contribution
of this study included moving beyond college student samples to lend insight into nonmedical use across a spectrum of young adults (Kelly et al., 2013). Additionally, results from
the 2013 Monitoring the Future (MTF) survey demonstrated that annual prevalence rates of
Adderall misuse were somewhat higher for college students (9.0%), but 6.7% of their noncollege peers also endorsed the behavior (Johnston, O'Malley, Bachman, & Schulenberg,
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2013). Further, prevalence rates of Ritalin misuse are much lower than rates of Adderall but
rates were not different for college students (1.8%) and non-college students (2.6%).
Clearly, NMUPS is not limited to undergraduate students. Further, although most
research suggests higher rates of this behavior in college student populations, prevalence
rates are also concerning in their non-college counterparts (e.g., 6.7%; Johnston et al., 2013).
Moreover, academic-related motives for NMUPS (e.g., improve academic performance) are
undoubtedly more salient among college students, but it is likely that non-academic related
motives (e.g., appetite suppression) are just as prevalent among non-college populations.
Research is warranted to examine NMUPS in a national sample of young adults to gain a
more comprehensive picture of the behavior, specifically as it relates to weight loss.
Gaps in the Research
Although promising, limitations of the existing research concerning NMUPS for
weight loss include the exclusive use of college student samples and relatively little attention
to relevant health behavior theory. Because NMUPS for weight loss is associated with poor
psychosocial health and health-jeopardizing behaviors, further research is warranted to
examine factors such as motivations and attitudes that are amenable to change. The paucity
of literature also warrants further investigation of individuals’ knowledge of risks of the
medication, negative consequences associated with NMUPS, age of onset, and how they
decided to try this behavior. The current study has attempted to address these gaps in the
literature.
The Current Study
This innovative study investigated NMUPS for weight loss in a national, young adult
sample, and assessed its relation with other problematic cognitions and health behaviors,
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including disordered eating. In addition, motivations and attitudes about NMUPS were
evaluated, as these constructs might be most amenable to change in a future intervention.
Moreover, this investigation focused on users who did not actually have a prescription but
received medication from another source (i.e., non-medical use), as these individuals are
typically at greater risk for adverse effects (e.g., cardiac effects; Benson, Flory, Humphreys,
& Lee, 2015). Accordingly, this project’s specific aims and relevant corresponding
hypotheses were:
Aim 1: To examine the prevalence of NMUPS for weight loss in a broader, national
sample of young adults. Young adults, ages 18-25, were recruited because they are the group
most likely to engage in NMUPS (SAMHSA, 2012) and are also at high risk for disordered
eating behaviors (Neumark-Sztainer et al., 2011).
Aim 2: To investigate correlates of NMUPS for weight loss, including negative
consequences associated with this misuse (e.g., medical, psychological), age of onset, factors
influencing participants’ decision to use prescription stimulants for weight loss, knowledge
about these medications (e.g., adverse effects, contraindications), medication source, and
perceived effectiveness of NMUPS for weight loss.
Aim 3: To evaluate the utility of the TPB model to predict membership in one of
three groups: individuals who have engaged in NMUPS for weight loss in the past year;
individuals who have tried to lose weight via other methods in the past year; and those who
have not tried to lose weight in the past year.
Hypothesis for Aim 3: Individuals who have engaged in NMUPS for weight loss will
have more favorable attitudes toward the behavior (e.g., view the behavior as ethical), view
the behavior as common, and have lower perceived behavioral control to lose weight without
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the help of stimulants, as well as higher perceived behavioral control to obtain stimulant
medication compared to the other two groups.
Aim 4: To compare the three groups on additional relevant behaviors and constructs:
disordered eating behaviors, body image, other substance use, and depressive
symptomatology.
Hypothesis for Aim 4: The three groups will differ on various constructs, such that
individuals who engage in NMUPS for weight loss will have poorer body image, higher rates
of disordered eating, higher rates of other substance use, and greater depressive
symptomatology compared to the other two groups.
Method
Research Design
Amazon’s Mechanical Turk. The current study utilized a survey aimed at assessing
NMUPS for weight loss in a national sample of young adults recruited from Amazon’s
Mechanical Turk (MTurk), an increasingly popular online method for recruiting large
samples at relatively low cost. Online data collection, particularly regarding surveys, is
popular and increasingly trusted in the scientific community (e.g., Casler, Bickel, & Hackett,
2013). This data collection poses no greater concern to data integrity and quality compared
with more traditional data collection methods (e.g., Casler et al., 2013). In particular, recent
research has demonstrated that MTurk samples are diverse, data can be collected efficiently
and inexpensively, data quality are high, and there is incentive to take the time to complete
tasks satisfactorily. Further, recent literature, such as a paper by Mason and Suri (2012) has
included steps and “how to” information for researchers that might be interested in utilizing
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MTurk (Casler et al., 2013). MTurk has been successfully used to recruit participants for
survey, longitudinal, and experimental research (Shapiro, Chandler, & Mueller, 2013).
Brief overview. MTurk started out in 2005 as a platform for humans to complete tasks
that are extremely difficult or impossible for computers (e.g., audio transcription), and has
since also become a place for scientists to conduct behavioral research (Mason & Suri, 2012).
In MTurk language, this online labor market allows for employers (called requesters; e.g.,
researchers) to post a task, or HIT (Human Intelligence Task; e.g., online survey) for
prospective employees (called workers; participants) to complete in exchange for a wage
(called reward; incentive; Paolacci, Chandler, & Ipeirotis, 2010). MTurk is a crowdsourcing
site with one of the largest participant pools, thus data can be obtained quickly. There is
typically a stable pool of potential participants from which to recruit inexpensively (Ipeirotis,
2010; Mason & Suri, 2012). Prior research demonstrates rapid data collection rates (Mason
& Suri, 2012; Shapiro et al., 2013). For example, Shapiro and colleagues (2013) recruited
participants to complete a study on well-being and mental health, which included items
assessing depression, anxiety, satisfaction with life, and personality. The survey took
approximately 20 minutes to complete and participants were given $0.75 as an incentive. The
authors collected data from 530 participants in two days. Additionally, Ipeirotis (2010) had
participants complete a survey assessing demographics and information regarding MTurk
participation that took approximately 3 minutes to complete. Participants were given $0.10
for participation. The survey was conducted over a three week period, and they collected data
from 1000 MTurk participants.
Low cost. One main advantage of MTurk is the low cost of conducting studies (with
built-in payment mechanism; Mason & Suri, 2012; Paolacci et al., 2010). Incentives can be
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as low as $0.01 and rarely exceed $1.00 (Paolacci et al., 2010). In terms of an hourly wage,
the average MTurk participant is willing to work for $1.40 an hour (Paolacci et al., 2010). A
concern often posed is that lower pay equals lower quality work, however, as will be
discussed subsequently, this is typically not the case and there seems to be little to no
influence of incentive on the quality of work (Mason & Suri, 2012). For example, Mason and
Watts (2009) found that the number of tasks participants completed increased with greater
incentive (from $0.01 to $0.10) but that the data quality were the same. Moreover, 69.6% of
U.S. MTurk workers reported that “MTurk is a fruitful way to spend free time and get some
cash (e.g., instead of watching TV)” (Ipeirotis, 2010; Mason & Suri, 2012; Paolacci et al.,
2010). Many people find MTurk money as a nice way to pay for “extras” (Mason & Suri,
2012). Non-monetary motivations include: for entertainment purposes and “killing time.”
Thus, most people are not trying to make a living using MTurk (less than 8% reported
earning greater than $50/week), and many are willing to participate for lower pay than they
might otherwise (Mason & Suri, 2012).
Diverse participant pool. Another major benefit of using MTurk is the recruitment of
diverse participants. Research has shown that MTurk samples are more diverse than college
student samples and that recruiting very large samples is feasible (Mason & Suri, 2012;
Shapiro et al., 2013). Demographic surveys show that MTurk participants from the United
States are similar to the national population, and that they are much more representative than
participants from traditional university subject pools, though they are typically younger than
the general population (Paolacci et al., 2010). Participants come from widespread geographic
locations, are more ethnically diverse, and economically varied compared to typical
academic samples (Casler et al., 2013). Moreover, MTurk samples are also more diverse in
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terms of ethnicity and economic status compared with samples recruited via social media
(e.g., Facebook, Twitter; Casler et al., 2013). MTurk samples are comparable in demographic
characteristics to community-based samples and the relations between key demographic
characteristics (e.g., age, gender) and health behaviors are similar for MTurk and community
samples (Shapiro et al., 2013). In addition, the estimated prevalence of mental health
problems (depression, social anxiety, substance use) found in MTurk samples closely
matches those of the U.S. population (Shapiro et al., 2013).
Good data quality. Prior research suggests the data quality from MTurk are high
(Mason & Suri, 2012; Paolacci et al., 2010; Shapiro et al., 2013). For example, Buhrmester
and colleagues (Buhrmester, Kwang, & Gosling, 2011) compared personality data collected
from MTurk with data collected using the same measures in traditional settings and found
concordance in findings. There was no evidence of random or otherwise problematic
responding in the data collected on MTurk and the psychometric properties (e.g., test-retest
correlations, coefficients alpha) of surveys using the two formats were nearly identical.
Shapiro et al. (2013) also found satisfactory internal and test-retest reliability for mental
health measures on MTurk. Moreover, they demonstrated criterion validity by replicating
established associations between psychopathology and demographic predictors (e.g.,
unemployment).
Casler and colleagues (2013) took a behavioral, traditionally in-person task and
converted it to an online format. Participants were shown four pairs of simple tools: one
familiar object demonstrated performing its typical function and one highly similar (in
appearance) novel object. In one condition, the “teaching” trials, the novel tool was named
and shown performing its action. In the “non-teaching” trials, the tool was named but only
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described in terms of non-functional features (e.g., color). In the in-person condition,
participants were allowed to hold the tools, and in the online format, participants viewed
videos with close-up shots of the objects three times. Participants were then introduced to a
different, unrelated task and were asked to choose which tool they needed to complete the
task. The authors then compared responses of participants recruited from MTurk, participants
recruited from social media postings, and a traditional sample of college students who
completed the task at a lab in-person. The expected behavioral outcome (i.e., choosing the
novel tool in non-teaching trials and no preference for novel tool in teaching trials) was
evident in all three recruitment conditions; thus, there was no difference in the response
pattern among the groups. The authors concluded that online recruitment and testing, and
MTurk in particular, can be a valid, and sometimes, even superior method than in-person
data collection. Additionally, Gardner and colleagues (Gardner, Brown, & Boice, 2012) used
MTurk to investigate body size estimation and dissatisfaction, and compared the results of
this study to those of three prior studies. All four of these studies used the same assessment
scale (i.e., Body Image Assessment Scale; Gardner, Jappe, & Gardner, 2009), but employed
different methodologies (group data collected in a classroom, individually in a lab, and
online via a university student web portal). Despite the different methodologies and sample
characteristics, comparable values were obtained in all four studies. The authors agreed with
Buhrmester et al. (2011) that quality data can be obtained inexpensively on MTurk, and that
MTurk is a viable method for collecting data related to body image and other areas of
psychology.
Moreover, MTurk has an approval rating system based on prior performance on other
MTurk “tasks” (e.g., surveys). Poor performance can lead to “rejection” of participants’ work,
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thus reducing participants’ approval ratings, which can subsequently impact their
participation in additional work including research studies. Further, researchers can require
participants to have an approval rating above a certain threshold. This rating system serves as
an incentive for participants to take tasks seriously (Casler et al., 2013). Gardner et al. (2012)
also noted that some participants are interested and motivated by the tasks.
Participant anonymity. An additional benefit is the anonymous nature of MTurk,
where participant identities are masked from researchers thus increasing response rates
(Shapiro et al., 2013). Prior work indicates that stigmatized health behaviors are more likely
to be fully reported as anonymity increases and that computer assessments can be an
important tool for data collection in this regard (Des Jarlais et al., 1999; Gosling, Vazire,
Srivstava, & John, 2004). Studies assessing sensitive information such as substance use and
eating disordered behaviors may well obtain more accurate data using web-based
technologies than traditional methods.
Creating a survey on MTurk. There are two ways to create HITs, or surveys, on
MTurk: internal or external HITs (Mason & Suri, 2012). An internal HIT consists of using
templates offered by Amazon. The development and all of the data collection are completed
on Amazon’s servers. These HITs can be created quickly and with little HTML programming
knowledge. However, a disadvantage is that they are limited to only single-page surveys. In
an external HIT, the survey and data are stored on the researcher’s server. Advantages
include increased control over the content and presentation of the survey (allowing multiple
pages in a survey), and that the data are secure because they are not stored on Amazon’s
servers as in an internal HIT. (Although Amazon says they will not touch the data, this is still
a privacy concern, especially for behavioral researchers examining sensitive issues.)
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Procedure
The current study utilized an online survey placed on Amazon’s Mechanical Turk
website via an external HIT. Participants were able to view the title of the survey, description,
number of timeslots available, and incentive amount. Additionally, the purpose of the study,
risks/benefits of participating in the research, and contact information for the Principal
Investigator (PI) and the university’s Institutional Review Board were provided in case the
participant experienced distress as a result of the research. Participants provided informed
consent by reading over the informed consent document and clicking on an “Agree” button
(or “Cancel” if they did not want to participate), and then continued onto the survey. The PI
frequently checked how many participants completed the survey, and subsequently approved
participants’ work, which enabled them to be paid.
Security. Data were never stored on Amazon’s servers, but went directly from the
participant to an external server managed by the PI. As an added security measure, the https
protocol was used so that participants’ responses were encrypted during the data transfer
process (Mason & Suri, 2012; Schmidt, 2007).
Quality assurance. Although rare, some workers simply care about the money they
earn and not the quality of their work (typically referred to as spammers; Mason & Suri,
2012). Additionally, there have been reports of programs (i.e., bots) that are designed to
automatically complete HITs (Mason & Suri, 2012), which can negatively impact data
quality. However, one safeguard from these occurrences is the inclusion of a question created
to discourage spammers and bots; this type of question must require human knowledge and
equal effort as additional questions in the survey, but have a verifiable answer (Mason & Suri,
2012). This/these question(s) can be used to evaluate the work. Choosing questions with
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topics that are not in line with the remainder of the study, should be clear to participants
(workers) that they have been included to verify the legitimacy of the other survey responses.
Five such questions were included in the current study. (It was made clear in the description
of the study that participants who did not answer these questions correctly, would not be
paid; Mason & Suri, 2012). To ensure both maximum data retention and fairness to
participants, the PI paid participants who correctly answered four out of the five quality
assurance questions (e.g., paid them and kept their data even if they skipped the “What do
you think the purpose of this study was?" question).
Participants
Power analysis. As the goal of Aim 4 was to compare/contrast those who engaged in
NMUPS for weight loss, those trying to lose weight via other methods, and those not trying
to lose weight, power to detect various effect sizes was explored using G*Power software.
The power analysis was based on the multivariate analysis of covariance (MANCOVA; see
analyses below), and the sample size required to detect a small effect size (Cohen, 1988) with
a power level of .80 and alpha set at .05 to detect differences between groups for a
MANCOVA was n = 64 for each group. In prior work, the prevalence of NMUPS for weight
loss has ranged from 4.4% to 11.7% (Jeffers & Benotsch, 2014; Jeffers et al., 2013). Taking
the conservative estimate into account (especially given that NMUPS is typically higher in
college/university samples), the PI planned to recruit at least 1455 (64/.044) participants to
obtain power ≥ .80. Moreover, the PI aimed to recruit at least 45 additional participants (for a
total n = 1500) to account for response error, poor quality responses, and missing data. The
power analysis thus facilitates detection of differences (i.e., small effect sizes) among the
three groups on multiple constructs (e.g., body dissatisfaction, depressive symptomatology)
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as a MANCOVA tests for multiple differences between groups. A sample size of 1500 was
also sufficiently large to estimate the prevalence of NMUPS for weight loss (Aim 1). The
power analysis for the MANCOVA was based on n = 192 (n = 64 x 3 groups). For the
structural equation model (SEM), almost the entire sample was included (n = 1429), which is
approximately seven times larger than the sample size on which the power analysis is based.
The sample size for the SEM was based on the groups for the dependent variable; please see
results section below. Therefore, the analyses were sufficiently powered (power > 0.80) to
detect a significant effect (p < 0.05) for parameters with low to moderate effect sizes in all
statistical models.
Eligibility criteria and incentive. Participants (n = 1526; see Descriptive Results
below), ages 18-25, were recruited from MTurk because they are the group most likely to
engage in NMUPS (SAMHSA, 2012) and are also at high risk for disordered eating
behaviors (Neumark-Sztainer et al., 2011). Participants were required to speak English and
reside in the United States. Additionally, only participants who had an approval rate of 90%
or greater (i.e., their work has been accepted by the requester or researcher at least 90% of
the time) were allowed to participate, which is a common qualification on MTurk (Mason &
Suri, 2012). They received $0.50 for their participation as low incentive rates are common in
MTurk and rarely exceed $1.00 (Paolacci et al., 2010).
Measures
The online survey allowed for branching of questions so that participants skipped
questions that did not pertain to them. For example, a participant who never endorsed
NMUPS was not subsequently asked about motivations for NMUPS. See Appendix A for the
entire list of measures.
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Demographics. Participants were asked their age, race/ethnicity, gender, educational
status, income, height, weight, whether they had ever been prescribed a prescription
stimulant medication by a doctor to treat ADHD (e.g., Adderall, Ritalin), whether they were
currently being prescribed a prescription stimulant medication by a doctor to treat ADHD
(e.g., Adderall, Ritalin), whether they had a current prescription for any medication for the
purpose of weight loss, whether they had ever tried to lose weight, whether they were
currently trying to lose weight, how often they had tried to lose weight during the last year,
place of residence (state), and whether they lived in a rural versus urban area. Body mass
index (BMI) was calculated based on self-reported height and weight.
Quality assurance questions. To discourage spammers and bots, as well as to ensure
good quality data, five verifiable questions were included: “Who is the president of the
United States?,” “What would you want your last meal to be?,” “Please check the number
four below: 1, 2, 3, 4, 5, 6,” “While watching the television, how often have you ever had a
fatal heart attack?” (Response choices were: Never, Rarely, Sometimes, On a regular basis.),
and “What do you think the purpose of this study was? (Please make your best guess.).”
(Mason & Suri, 2012).
NMUPS frequency. NMUPS was assessed with the following question: “On how
many occasions (if any) in (a) your lifetime or (b) the past 12 months have you used a
prescription stimulant normally used to treat ADHD (e.g., Adderall, Ritalin, Concerta,
Vyvanse), not prescribed to you?” The response scale ranged from 1 (No occasion) to 7 (40
or more occasions). This question was modeled off of other commonly used questions to
assess NMUPS (Johnston, O’Malley, Bachman, & Schulenberg, 2005; McCabe & Teter,
2007; McCabe et al., 2011).
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NMUPS motivations. Participants who had ever engaged in NMUPS answered
questions concerning motivations for non-medical use including “weight loss/appetite
suppression,” “to get high,” “increased energy,” and “to increase concentration.” Motivations
were assessed for lifetime and past year use. Similar items have been used in prior work
(Jeffers & Benotsch, 2014).
Age of onset. Participants who had ever engaged in NMUPS reported at what age
they began using stimulants non-medically. One question also specifically asked about age of
onset for those who used non-medically for weight loss.
How they decided to try this as a weight loss strategy. One question addressed how
an individual who engaged in NMUPS for weight loss decided to try this as a weight loss
strategy: a) You knew someone else who was doing it, b) You heard about the idea from the
media (e.g., TV, radio, Internet), c) Someone else gave you their ADHD medication
specifically for that purpose, d) Other _______.
Medication source. Those who had engaged in NMUPS reported on the source of the
medication: a) Friends, b) Family, c) Internet, d) Stranger, e) Other. This item has been used
in prior work (Jeffers & Benotsch, 2014).
Perceived effectiveness of NMUPS for weight loss. Participants reported on the
perceived effectiveness of NMUPS for weight loss from 1 (Not at all effective) to 4 (Very
effective) as done in prior work (Jeffers & Benotsch, 2014).
Negative consequences associated with NMUPS. Participants who had engaged in
NMUPS reported on negative consequences experienced as a result. Items were adapted from
a Drug Use Consequences Scale developed by Palmer et al. (Palmer, McMahon, Moreggi,
Rounsaville, & Ball, 2012) and the Shortened Inventory of Problems—Alcohol and Drugs by
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Blanchard and colleagues (Blanchard, Morgenstern, Morgan, Lobouvie, & Bux, 2003),
which was modified from its parent scale, the Inventory of Drug Use Consequences by
Miller et al. (Miller, Tonigan, & Longabaugh, 1995). Examples include: “lost a close
relationship” and “continued to use despite psychological or physical consequence.” The
response scale ranged from 0 (Never) to 7 (40+ times in past year).
Medication knowledge. This section assessed participants’ knowledge of stimulant
medication including side effects and adverse consequences, contraindications, as well as
sources of exposure regarding this information, modeled after Judson and Langdon (2009).
Items were also developed based off of the Physicians’ Desk Reference ("Adderall XR,"
2014; "Ritalin LA," 2014; and "Vyvanse," 2014).
Attitudes. Attitudes were assessed with questions regarding beliefs about adverse
health effects and ethical considerations, modeled after a sample TPB questionnaire (Ajzen,
n.d.-a) and Judson and Langdon (2009). Sample items include: “I believe it is safe for people
to use stimulant medication in excess or for purposes other than prescribed by a physician”
and “It is ethical for people without diagnosed ADHD to use stimulant medication for any
reason.” The response scale ranged from 1 (Strongly Disagree) to 7 (Strongly Agree).
Subjective norms. Subjective norms were assessed with questions regarding social
acceptability of use and perceptions of close others’ beliefs regarding NMUPS. Items were
modeled after a sample TPB questionnaire (Ajzen, n.d.-a) and Judson and Langdon (2009).
Sample items include: “I know at least one person (e.g., family member/friend/significant
other) who misuses his/her own stimulant medication for the purpose of weight loss/appetite
suppression” and “I believe the use of stimulant medication by people without diagnosed
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ADHD, is common.” The response scale ranged from 1 (Strongly Disagree) to 7 (Strongly
Agree).
Perceived behavioral control. Perceived behavioral control assessed participants’
perceptions of their ability to lose weight without the use of stimulants. Items were modeled
after a sample TPB questionnaire (Ajzen, n.d.-a) and Judson and Langdon (2009). Sample
items include: “I feel I do not need stimulant medication to help me lose weight/control my
appetite” and “I am confident that I could get a stimulant medication from someone if I
wanted to.” The response scale ranged from 1 (Strongly Disagree) to 7 (Strongly Agree).
Disordered eating behaviors. The Eating Disorder Examination-Self-report
Questionnaire (EDE-Q; Fairburn & Beglin, 1994), which has demonstrated validity in both
men and women (Lavender, De Young, & Anderson, 2010; Rose, Vaewsorn, RosselliNavarra, Wilson, & Weissman, 2013), was used to measure disordered eating behavior and
attitudes. It assesses engagement in binge episodes and a range of compensatory behaviors,
including self-induced vomiting, laxative use, excessive exercise, and dietary restraint within
the past 28 days. A sample item includes: “On how many of the past 28 days, have you had a
definite fear that you might gain weight?” The response scale for this particular item ranged
from 0 (No days) to 6 (Every day).
Healthy and unhealthy weight loss behaviors. Items from Neumark-Sztainer et al.’s
(2011) Project EAT-III Survey, were used to assess both healthy (e.g., exercise, ate less
sweets) and unhealthy weight loss behaviors (e.g., fasted, used diuretics) participants had
engaged in over the past 12 months. An energy drink item was also added as an unhealthy
weight loss behavior (Jeffers, Vatalaro-Hill, & Benotsch, 2014). The response scale ranged
from 1 (Never) to 4 (On a regular basis).
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Body dissatisfaction. The Appearance Evaluation subscale of the Multidimensional
Body Self-Relations Questionnaire (MBSRQ; Brown, Cash, & Mikulka, 1990) was used to
assess body dissatisfaction. The MBSRQ is a 69-item questionnaire that assesses attitudes
toward the body and body image, and has demonstrated validity in both men and women
samples (Cash, Morrow, Hrabosky, & Perry, 2004). The Appearance Evaluation subscale (7
items) assesses how satisfied one is with the appearance of one’s body. Sample items
include: “I like my looks just the way they are” and “I am physically unattractive.” The
response scale ranged from 1 (Definitely disagree) to 5 (Definitely agree).
Media influence on body image. The Sociocultural Attitudes Towards Appearance
Questionnaire-3 (SATAQ-3; Thompson, van den Berg, Roehrig, Guarda, & Heinberg, 2004)
is a widely used, self-report questionnaire that assesses various sociocultural influences on
body image and eating disturbances, and has demonstrated both reliability and validity in
studies with women and men (Karazsia & Crowther, 2008). This measure has four subscales:
the internalization of media, both generally and related to athleticism; pressures; and
information. However, only the pressures subscale was used in the current study as it has
previously been shown to account for significantly more variance in body dissatisfaction than
the other three subscales (Thompson et al., 2004). The pressures subscale assesses perceived
pressures from the media to achieve the sociocultural appearance ideal. A sample item
includes: “I've felt pressure from TV or magazines to have a perfect body.” The response
scale ranged from 1 (Definitely disagree) to 5 (Definitely agree).
Depressive symptomatology. The Center for Epidemiologic Studies Depression
Scale-Revised (CESD-R; Eaton, Muntaner, Smith, Tien, & Ybarra, 2004) was used to assess
depressive symptomatology. This is a valid and reliable instrument that has wide
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applicability in the general population (Van Dam & Earleywine, 2011). A sample item
includes: “Nothing made me happy.” The response scale ranged from 0 (Not at all or less
than 1 day) to 4 (Nearly every day for 2 weeks).
Other substance use. Participants reported on other recreational drugs and
substances used within the past year. Similar items have shown utility in prior work
(Benotsch, Perschbacher Lance, Nettles, & Koester, 2012).
Data Analysis
All data were analyzed using SPSS 22, except for the SEM analysis, which was
conducted using Mplus version 7.31.
First aim. The first aim of this study was to examine the prevalence of NMUPS for
weight loss in a broader, national sample of young adults. Frequency rates were calculated to
assess the number and percentage of participants who had ever engaged in NMUPS for
weight loss (i.e., lifetime users). Additionally, lifetime frequency rates were calculated to
assess the percentage of participants who had engaged in NMUPS for other motivations. The
same frequency statistics were conducted to assess past year use.
Second aim. The second aim of this study was to investigate correlates of NMUPS
for weight loss, including negative consequences associated with this misuse, age of onset,
factors influencing participants’ decision to use prescription stimulants for weight loss,
knowledge about these medications, medication source, and perceived effectiveness of
NMUPS for weight loss. Frequency statistics were used to calculate the types of negative
consequences experienced, how individuals decided to try NMUPS for weight loss, amount
of knowledge concerning the medication, medication source, and perceived effectiveness.
Descriptive statistics (mean, range) were used to describe the age of onset for the behavior.
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Third aim. The third aim of this study was to evaluate the utility of the TPB model
to predict membership in one of three groups: individuals who have engaged in NMUPS for
weight loss in the past year; individuals who have tried to lose weight via other methods in
the past year; and those who have not tried to lose weight in the past year. However, given
that the outcome was multinomial (i.e., three weight loss groups), Mplus would not provide
the desired fit statistics. Thus, to obtain fit statistics, participants who had not tried to lose
weight in the past year were removed from the analysis as they had not endorsed one of the
main variables of interest, and as such, are a less interesting group. A SEM with weighted
least squares means and variance adjusted (WLSMV) estimation was conducted to examine
the overall fit of attitudes toward NMUPS for weight loss; social norms regarding NMUPS
for weight loss; and perceived behavioral control to lose weight without stimulants, as well
as to obtain stimulant medication, as predictors of engaging in past year NMUPS for weight
loss.
SEM allows for the estimation of latent variables (e.g., attitudes) compared to
observed variables only, thus eliminating random error (Hays, Revicki, & Coyne, 2005).
SEM also allows comparisons between an observed variance/covariance matrix (i.e., the
current data) and a hypothesized or implied variance/covariance matrix (i.e., TPB), to
determine how well the theoretical model fits the given data. The chi-square test and the root
mean square error of approximation (RMSEA) were used to assess the model fit. A p > .05
for the chi-square test and a RMSEA < .06 were used to indicate a good model (Hu &
Bentler, 1999; Tucker & Lewis, 1973).
Questionnaire items related to the TPB were used as indicators to examine the latent
constructs in the SEM. Because some of these items were developed for the current study (a
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standard practice for TPB measures; Ajzen, n.d.-b), factor analysis was performed to test that
items adequately fit their respective constructs and to remove any poorly fitting items prior to
fitting the SEM. Further, examining the amount of predictive variance of each latent
construct in the model allows for testing of the hypothesis for aim 3: Individuals who have
engaged in NMUPS for weight loss will have more favorable attitudes toward the behavior
(e.g., view the behavior as ethical), view the behavior as common, and have lower perceived
behavioral control to lose weight without the help of stimulants, as well as higher perceived
behavioral control to obtain stimulant medication compared to the other group.
Fourth aim. The fourth aim of this study was to compare the three groups on
additional relevant behaviors and constructs: disordered eating behaviors, body image, other
substance use, and depressive symptomatology. A MANCOVA was conducted to compare
the three groups on the following continuous dependent variables: body dissatisfaction,
media influence on body image, eating attitudes, and depressive symptomatology. The
following covariates were included: gender, age, race/ethnicity, educational status, and BMI.
Although results have been inconsistent, NMUPS for weight loss has been associated with
being White and having a lower BMI (Jeffers & Benotsch, 2014; Jeffers et al., 2013). Chisquare analyses were also performed to compare the two weight loss groups on the following
dichotomous outcomes: disordered eating behaviors and engagement in healthy and
unhealthy weight loss behaviors. A chi-square analysis was also performed to compare the
three groups on other substance use. Bonferroni post-hoc tests were conducted if significant
differences were found between groups. Conducting the MANCOVA and chi-square
analyses allowed for the testing of significant differences between group means, thus
allowing for the testing of the hypothesis for aim 4: The three groups will differ on various
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constructs, such that individuals who engage in NMUPS for weight loss will have poorer
body image, higher rates of disordered eating, higher rates of other substance use, and greater
depressive symptomatology compared to the other two groups.
Results
Descriptive Results
Data were collected from September 2014 thru February 2015. A total of 1856
surveys were submitted on MTurk. Three-hundred and thirty entries were removed from
analyses due to one of five reasons: the participant 1) was outside of the 18-25 year age range
(or missing age; age range from 18-70 years), 2) voluntarily completed the survey twice, 3)
incorrectly answered two or more of the quality assurance questions, 4) encountered a
technical error where the same survey was submitted more than once, or 5) resided outside of
the United States. See Table 1. (Participants who were outside of the age range or resided
outside of the United States were allowed to complete the survey due to some errors with
initial implementation of the MTurk survey.)
Table 1.
Reasons entries were deleted from MTurk.

Reason Deleted

n

%

Outside of Age Range (or Missing Age)

177

9.5

Voluntarily Completed Survey Twice

109

5.9

Quality Assurance Questions

37

2.0

Duplicate Survey (Due to Technical Error)

4

0.22

Location

3

0.16
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n = 1856.
The total usable n = 1526. The mean age of the participants was 22.32 years (SD =
2.05) and the sample consisted of 955 females (62.6%), 538 males (35.2%), and 33
transgender (2.2%) individuals. The majority of the sample was White (74.4%), followed by
African-American (8.5%), Hispanic/Latino (6.9%), Asian-American (6.7%), other
race/ethnicity (2.6%), and Native American participants (0.9%). Participants’ BMI ranged
from 12.75 to 68.52 (M = 26.07, SD = 7.24), indicating a slightly overweight sample.
Approximately 17.0% of individuals reported having a high school diploma/GED or less than
a high school education. The remaining 83.0% had completed at least one year of
college/university or higher (e.g., had a four-year college degree). A plurality of participants
reported a total household income of $0-25,999 (37.6%) for the previous year, followed by
$26,000-51,999 (30.6%), more than $75,000 (12.9%), $52,000-74,999 (12.4%), and 6.5%
reported that they “didn’t know/declined to say.” Approximately 15.0% of participants
reported ever being prescribed a prescription stimulant medication by a doctor to treat
ADHD. Based on data from the 2010 census (U.S. Census Bureau, 2014a), participants’ state
residencies were highly representative of the U.S. population (r = .97, p < .001). To calculate
this statistic, states were listed by population rank and then participant frequencies from the
current dataset were entered to correspond with the state rankings. Next, a correlation was
run between participant home states and the 2010 census data on state populations for the
U.S. The state represented the most was California (n = 154) and the least represented state
was Wyoming (n = 1). The majority of participants were from urban (72.5%) versus rural
(27.5%) areas.
First Aim
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Approximately one-third (33.1%) of participants reported that they had ever engaged
in NMUPS (n = 507), with 51.0% of these individuals reporting past year use (n = 258). Of
those reporting lifetime NMUPS, 36.2% of participants reported engaging in NMUPS for
weight loss (n = 184), or 12.1% of the total sample. Of those reporting NMUPS for weight
loss, 48.4% reported past year use (n = 89). The top five reported motivations for engaging in
NMUPS in one’s lifetime were: to increase concentration (77.4%), to increase energy
(77.0%), as a study aid (72.3%), to increase alertness (67.5%), and to get high (57.0%).
Weight loss was the twelfth most commonly-reported lifetime motivation. See Table 2. The
top five reported motivations for past year NMUPS were: to increase concentration (73.7%),
to increase energy (72.8%), to increase alertness (68.0%), as a study aid (66.0%), and to get
high (53.1%). Weight loss was the eleventh most commonly-reported past year motivation.
See Table 3.
Table 2.
Frequencies of NMUPS motivations—lifetime.
NMUPS Motivation—
Lifetime
To increase concentration
Increased energy
Study aid
Because it helps increase
my alertness
To get high
Because of
experimentation
To try something new
To reduce anxiety
Pain relief
Coping with a difficult
problem

n

Percentage of Those
Reporting NMUPS

Percentage of Total n

393
389
365
340

77.4
77.0
72.3
67.5

25.8
25.5
23.9
22.3

289
286

57.0
56.9

18.9
18.7

274
262
218
203

54.0
52.1
43.1
40.2

18.0
17.2
14.3
13.3
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NMUPS Motivation—
Lifetime
To forget my worries
Weight loss/appetite
suppression
To feel more selfconfident
To fit in and not be
excluded
Because it’s safer than
street drugs
Sexual stimulant
Because it counteracts the
effects of other drugs
Because I’m addicted

n

Percentage of Those
Reporting NMUPS

Percentage of Total n

197
184

39.4
36.2

12.9
12.1

177

35.0

11.6

104

20.8

6.8

93

18.4

6.1

92
90

18.2
17.8

6.0
5.9

44

8.8

2.9

Note. n ranges from 500-508.
Table 3.
Frequencies of NMUPS motivations—past year.

NMUPS Motivation—
Past Year
To increase concentration
Increased energy
Because it helps increase
my alertness
Study aid
To get high
To reduce anxiety
To try something new
Because of
experimentation
Coping with a difficult
problem
To feel more selfconfident
To forget my worries

188
185
172

Percentage of Those
Reporting Past Year
NMUPS
73.7
72.8
68.0

167
136
125
95
93

66.0
53.1
49.2
37.5
36.9

10.9
8.9
8.2
6.2
6.1

93

36.8

6.1

92

36.5

6.0

91

35.8

6.0

n
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NMUPS Motivation—
Past Year
Weight loss/appetite
suppression
Pain relief
Because it counteracts the
effects of other drugs
Because it’s safer than
street drugs
Sexual stimulant
To fit in and not be
excluded
Because I’m addicted

89

Percentage of Those
Reporting Past Year
NMUPS
35.2

87
54

34.7
21.2

5.7
3.5

51

20.1

3.3

47
44

18.6
17.3

3.1
2.9

29

11.4

1.9

n

Percentage of Total n
5.8

Note. n ranges from 251-256.
Second Aim
Female (13.6%) and transgender participants (24.2%) were more likely than males
(8.6%) to report engaging in NMUPS for weight loss, χ2(2) = 13.04, p = .001. White and
non-White participants reported similar rates of the behavior with 12.6% of Whites reporting
use and 10.5% of non-Whites reporting use, χ2(1) = 1.23, p = .268. Interestingly, there were
significant differences in education, with 15.8% of participants with a high school
diploma/GED or less than a high school education reporting use and 11.3% of participants
who had completed at least one year of college/university or higher reporting use, χ2(1) =
4.07, p = .044. Additionally, there were significant differences in age between participants
reporting NMUPS for weight loss (M = 22.67, SD = 1.96) and those who did not (M = 22.28,
SD = 2.06), t(1524) = -2.44, p = .015. There were also significant differences in BMI
between participants reporting NMUPS for weight loss (MRank = 832.79; M = 26.78, SD =
6.61) and those who did not (MRank = 749.97; M = 25.97, SD = 7.32), z = -2.40, p = .016.
Additionally, there were slight regional differences among individuals reporting this
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behavior: South—32.6%, Northeast—26.6%, West—21.7%, and Midwest—19.0%, with
slightly higher rates in the South and Northeast regions. However, there was only a
significant difference in reporting for the Northeast region, with 15.6% of individuals living
in the Northeast region reporting use, compared with 11.1% of individuals living in other U.S.
regions reporting use, χ2(1) = 4.69, p = .030. NMUPS for weight loss did not differ between
participants residing in rural (11.0%) versus urban (12.5%) areas, χ2(1) = 0.68, p = .411.
Participants reported that they started engaging in NMUPS for weight loss ranging
from 12 to 24 years (M = 18.16, SD = 2.71). Around 8.5% of participants reported starting
between the ages of 12-14 (approximate age during middle school), 33.4% reported starting
between the ages of 15-17 (approximate age during high school), and 58.2% reported starting
at age 18 and over. Participants also reported that they decided to try a prescription stimulant
without a doctor’s orders specifically for the purpose of weight loss/appetite suppressive
effects due to: knowing someone else who was doing it (48.9%), someone else giving his/her
ADHD medication specifically for that purpose (23.4%), hearing about the idea from the
media (e.g., TV, radio, Internet; 19.7%), and for other reasons not listed (8.0%). A vast
majority of participants reported receiving their stimulant medications from friends (82.1%),
followed by family (10.9%), the Internet (3.3%), a stranger (2.2%), and other sources (1.6%).
Interestingly, one participant reported getting the medication from a “teenager whose house I
was watching while they were away.” In terms of effectiveness, many participants reported
that engaging in NMUPS for weight loss was “mildly effective” (43.1%), followed by “very
effective” (21.3%), “somewhat effective” (18.1%), and “not at all effective” (17.6%).
Individuals also reported a number of consequences associated with NMUPS for
weight loss. The top five commonly-reported past year consequences were: enjoyed using
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stimulants (54.3%), lost weight or not eaten properly (52.0%), felt bad physically (46.6%),
felt guilty or ashamed (38.8%), and done impulsive things you later regretted (38.3%). See
Table 4. The top five commonly-reported consequences experienced in one’s lifetime, but
not in the past year, were: lost weight or not eaten properly (33.9%), enjoyed using
stimulants (33.0%), taken drugs in larger amounts or over a longer period of time than
planned (27.2%), felt bad physically (27.1%), and done impulsive things you later regretted
(26.9%). See Table 5.
Table 4.
Frequencies of negative consequences associated with NMUPS for weight loss—past year
consequences.
Negative Consequences—Past
Year
Enjoyed using drugs
Lost weight or not eaten properly
because of my stimulant use
Felt bad physically
Felt guilty or ashamed
Done impulsive things you later
regretted
Spent too much money or lost a lot
of money
Spent a significant amount of time
thinking about, looking for, or
using
Taken drugs in larger amounts or
over longer period of time than
you planned
Need more drugs to get the same
effect or don’t get the same effect
with the usual amount
Wanted or tried to limit, cut down,
or stop

n

Percentage of Those Reporting
NMUPS for Weight Loss

99

54.3

95

52.0

84
71

46.6
38.8

70

38.3

68

37.2

67

36.6

67

36.3

66

36.1

62

33.7
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Negative Consequences—Past
Year
Failed to do what was expected of
you
Been unhappy because of my
stimulant use
Lost interest in activities or
hobbies
Missed school, work, or activities
with friends
Said or done something
embarrassing
Continued to use despite
psychological or physical
consequence
Performed poorly at school or
work
While using stimulants I said
harsh or cruel things to someone
Take more to avoid or reduce
withdrawal
My personality has changed for
the worse
Needed medical treatment
Gotten into a physical fight
Lost a close relationship
Gotten into legal trouble or
arrested
Had to go to the Emergency Room
(ER)
Been suspended, expelled from
school, or fired from work

n

Percentage of Those Reporting
NMUPS for Weight Loss

61

33.5

59

32.8

59

32.0

56

30.6

53

29.0

50

27.4

46

25.0

45

24.9

41

22.2

32

17.4

23
22
22

12.5
11.9
11.9

21

11.7

18

9.7

14

7.5

Note. n ranges from 181-184.
Table 5.
Frequencies of negative consequences associated with NMUPS for weight loss—lifetime but
not past year consequences.
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Negative Consequences—
Lifetime But Not Past Year
Lost weight or not eaten properly
because of my stimulant use
Enjoyed using drugs
Taken drugs in larger amounts or
over longer period of time than
you planned
Felt bad physically
Done impulsive things you later
regretted
Said or done something
embarrassing
Felt guilty or ashamed
Been unhappy because of my
stimulant use
Need more drugs to get the same
effect or don’t get the same effect
with the usual amount
Lost a close relationship
My personality has changed for
the worse
Continued to use despite
psychological or physical
consequence
Spent a significant amount of time
thinking about, looking for, or
using
Wanted or tried to limit, cut down,
or stop
Failed to do what was expected of
you
Spent too much money or lost a lot
of money
While using stimulants I said
harsh or cruel things to someone
Missed school, work, or activities
with friends

n

Percentage of Those Reporting
NMUPS for Weight Loss

62

33.9

60

33.0

50

27.2

49

27.1

49

26.9

49

26.8

48

26.4

46

25.6

45

24.6

44

24.2

44

23.9

43

23.5

42

23.0

42

22.8

41

22.5

39

21.4

38

21.0

36

19.7
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Negative Consequences—
Lifetime But Not Past Year
Lost interest in activities or
hobbies
Performed poorly at school or
work
Take more to avoid or reduce
withdrawal
Gotten into a physical fight
Been suspended, expelled from
school, or fired from work
Had to go to the Emergency Room
(ER)
Gotten into legal trouble or
arrested
Needed medical treatment

n

Percentage of Those Reporting
NMUPS for Weight Loss

35

19.0

32

17.5

32

17.4

27

14.7

24

13.2

20

10.9

19

10.5

15

8.2

Note. n ranges from 181-184.
Individuals also answered questions concerning their knowledge of stimulant
medications. On a scale from “Strongly Disagree” to “Strongly Agree,” 76.5% of participants
reported that they agreed or strongly agreed with the statement: “I consider myself to be
knowledgeable about the side effects associated with the use of stimulant medication
normally used to treat ADHD (e.g., Adderall, Ritalin, Vyvanse).” See Table 6. The greatest
sources of exposure to information about side effects associated with the use of ADHD
medication include: the Internet (73.9%), other students/friends (46.7%), and in class
(33.7%). See Table 7. When presented with symptoms that either were or were not side
effects, the top five items that were answered correctly were: nighttime wakefulness
(insomnia) and reductions in appetite with 90.7% of individuals answering both correctly,
increase in heart rate (85.8%), dry mouth (73.9%), headache and anxiety with 72.3% of
participants answering both correctly, and tachycardia (excessively rapid heartbeat; 70.1%).
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The total mean score of side effects that were answered correctly was M = 60.33%. There
was a moderate correlation between participants’ confidence in their knowledge about side
effects and their actual knowledge (r = .28, p < .001). See Table 8. When presented with both
true and false contraindications, the top five items that were answered correctly were: history
of drug abuse (82.1%), serious cardiac (heart) problems (76.4%), during or within 14 days
following MAOI (antidepressant medication) use (49.5%), hyperthyroidism (43.5%), and
influenza (35.0%). The total mean score of contraindications that were answered correctly
was M = 42.88%. See Table 9.
Table 6.
Extent to which individuals consider themselves knowledgeable about side effects of
stimulant medications (of those reporting NMUPS for weight loss).

Knowledgeable of Side Effects

	
  
n	
  

Percentage

Strongly Disagree

7

3.8

Disagree

21

11.4

Neither

15

18.2

Agree

90

49.2

Strongly Agree

50

27.3

n = 183.
Table 7.
Frequencies— sources of exposure to information about side effects associated with use of
ADHD medication (of those reporting NMUPS for weight loss).
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Source

n

Percentage

Internet

136

73.9

Other students/friends

86

46.7

In class

62

33.7

Healthcare facility pamphlet

45

24.5

Television

40

21.7

Books

24

13.0

None

21

11.4

Parents

20

10.9

Magazine

18

9.8

Other

15

8.2

Information session

11

6.0

n = 184.
Table 8.
Frequencies—knowledge about medication: Side effects (of those reporting NMUPS for
weight loss).
Side Effect

Correct (n;
percentage)

Incorrect (n;
percentage)

Don’t Know (n;
percentage)

Nighttime
wakefulness
(insomnia)
Reductions in
appetite
Increase in heart
rate

166 (90.7)

12 (6.6)

5 (2.7)

166 (90.7)

10 (5.5)

7 (3.8)

157 (85.8)

15 (8.2)

11 (6.0)
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Side Effect

Correct (n;
percentage)

Incorrect (n;
percentage)

Don’t Know (n;
percentage)

Dry mouth
Headache
Anxiety
Tachycardia
(excessively rapid
heartbeat)
Agitation
Increase in blood
pressure
Dizziness
Adverse psychiatric
problems
Cardiovascular
adverse reactions
Sore throat
Vomiting
Abdominal pain
Diarrhea
Sudden death
Nausea

136 (73.9)
133 (72.3)
133 (72.3)
129 (70.1)

22 (12.0)
28 (15.2)
31 (16.8)
38 (20.7)

26 (14.1)
23 (12.5)
20 (10.9)
17 (9.2)

124 (67.4)
123 (67.2)

39 (21.2)
29 (15.8)

21 (11.4)
31 (16.9)

111 (60.7)
107 (58.2)

46 (25.1)
41 (22.3)

26 (14.2)
36 (19.6)

99 (54.1)

47 (25.7)

37 (20.2)

93 (50.5)
78 (42.6)
78 (42.4)
58 (31.5)
52 (28.4)
51 (27.9)

33 (17.9)
62 (33.9)
63 (34.2)
72 (39.1)
84 (45.9)
102 (55.7)

58 (31.5)
43 (23.5)
43 (23.4)
54 (29.3)
47 (25.7)
30 (16.4)

Note. n ranges from 183-184. Items listed in italics are possible side effects.
Table 9.
Frequencies—knowledge about medication: Contraindications (of those reporting NMUPS
for weight loss).
Contraindication

Correct (n;
percentage)

Incorrect (n;
percentage)

Don’t Know (n;
percentage)

History of drug abuse
Serious cardiac
(heart) problems
During or within 14
days following MAOI
(antidepressant
medication) use

151 (82.1)
139 (76.4)

16 (8.7)
22 (12.1)

17 (19.2)
21 (11.5)

91 (49.5)

24 (13.0)

69 (37.5)
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Contraindication

Correct (n;
percentage)

Incorrect (n;
percentage)

Don’t Know (n;
percentage)

Hyperthyroidism
Influenza
Crohn’s disease
Migraines
Glaucoma

80 (43.5)
64 (35.0)
39 (21.3)
36 (19.7)
33 (18.1)

31 (16.8)
26 (14.2)
35 (19.1)
68 (37.2)
53 (29.1)

73 (39.7)
93 (50.8)
109 (59.6)
79 (43.2)
96 (52.7)

Note. n ranges from 182-184. Items listed in italics are possible contraindications.
Third Aim
Factor analysis was performed to test that questionnaire items related to the TPB
adequately fit their respective constructs and to remove any poorly fitting items. The
extraction technique performed in this study was principal axis factoring, and promax
rotation was utilized as the rotation technique given that factors were expected to correlate.
To determine the number of factors to be retained, the Guttman-Kaiser rule (i.e., retain
factors with an eigenvalue larger than 1), scree plots, percentage of variance accounted for by
the factors, and congruency of items with the theory were considered.
The attitudes construct loaded onto three separate factors with an eigenvalue ≥ 1. The
first factor included five indicators of attitudes [eigenvalue = 4.33, R2 = .48; α = .88]. The
second factor included two indicators of attitudes [eigenvalue = 1.37, R2 = .15; α = .86].
Finally, the third factor included two indicators of attitudes [eigenvalue = 1.28, R2 = .14; α
= .84]. See Table 10 for the factor loadings of these items.
Table 10.
Factor loadings for the attitudes items.
Attitude Items

Factor
Loading
(Factor 1)

Factor
Loading
(Factor 2)
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Attitude Items

Factor
Loading
(Factor 1)

Factor
Loading
(Factor 2)

Factor
Loading
(Factor 3)

Mean (SD)

1. It is ethical for people
without diagnosed ADHD
to use stimulant medication
for any reason.

.739

-.051

.002

2.91 (1.68)

2. It is ethical for people
diagnosed with ADHD to
use stimulant medication in
excess or for purposes other
than prescribed by a
physician.

.764

.068

.014

2.65
(1.596)

3. It is ethical for people
with diagnosed ADHD to
use stimulant medication to
lose weight/control
appetite.

.892

-.043

-.058

2.84 (1.64)

4. It is ethical for people
without diagnosed ADHD
to use stimulant medication
to lose weight/control
appetite.

.886

-.045

-.021

2.67 (1.67)

5. I believe it is safe for
people to use stimulant
medication in excess or for
purposes other than
prescribed by a physician.

.523

.188

.148

2.17 (1.48)

6. I am concerned that
taking stimulant medication
in excess or for purposes
other than prescribed by a
physician will adversely
affect a person’s health.

-.063

1.022

-.011

5.46 (1.46)
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Attitude Items

Factor
Loading
(Factor 1)

Factor
Loading
(Factor 2)

Factor
Loading
(Factor 3)

Mean (SD)

7. I am concerned that
taking stimulant medication
to lose weight/control
appetite will adversely
affect a person’s health.

.060

.746

-.022

5.38 (1.47)

8. I feel that the benefits of
using a prescription
stimulant medication
without a doctor’s orders
for any reason outweigh the
potential risks.

-.020

-.017

.878

3.10 (1.86)

-.016

.846

3.02 (1.84)

9. I feel that the benefits of .013
someone misusing their
own prescription stimulant
medication for any reason
outweigh the potential risks.
n = 1422.

Similarly, a factor analysis was performed on the subjective norms items, and four
separate factors emerged with an eigenvalue ≥ 1. The first factor included four indicators of
subjective norms [eigenvalue = 3.18, R2 = .32; α = .83]. The second factor included two
indicators of subjective norms [eigenvalue = 2.02, R2 = .20; α = .95]. The third factor
included two indicators of subjective norms [eigenvalue = 1.47, R2 = .15; α = .85]. Finally,
the fourth factor also included two indicators of subjective norms [eigenvalue = 1.396, R2
= .14; α = .80]. See Table 11 for the factor loadings of these items.
Table 11.
Factor loadings for the subjective norms items.
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Subjective Norms Items

Factor
Loading
(Factor 1)

Factor
Loading
(Factor 2)

Factor
Loading
(Factor 3)

Factor
Mean
Loading
(SD)
(Factor 4)

1. It is socially acceptable
for people without
diagnosed ADHD to use
stimulant medication for
any reason.

.790

.079

-.130

.123

3.50 (1.78)

2. It is socially acceptable
for people diagnosed with
ADHD to use stimulant
medication in excess or
for purposes other than
prescribed by a physician.

.789

.066

-.094

.081

3.37 (1.74)

3. My
friends/family/significant
other believe that it is ok
for people without
diagnosed ADHD to use
stimulant medication for
any reason.

.711

-.071

.122

-.083

2.98 (1.74)

4. My
friends/family/significant
other believe that it is ok
for people diagnosed with
ADHD to use medication
in excess or for purposes
other than prescribed.

.688

-.093

.156

-.139

2.88 (1.67)

5. I know at least one
person (e.g., family
member/friend/significant
other) who uses stimulant
medications for the
purpose of weight
loss/appetite suppression
without a doctor’s
prescription.

-.026

.033

.851

.057

3.28 (2.21)
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Subjective Norms Items

Factor
Loading
(Factor 1)

Factor
Loading
(Factor 2)

Factor
Loading
(Factor 3)

Factor
Mean
Loading
(SD)
(Factor 4)

6. I know at least one
.029
person (e.g., family
member/friend/significant
other) who misuses his/her
own stimulant medication
for the purpose of weight
loss/appetite suppression.

.017

.834

.014

3.09 (2.11)

7. I value my friends’/
family’s/significant
other’s opinion on
whether or not it is ok for
people with a prescription
to use the stimulant
medication in excess or
for purposes other than
prescribed.

.014

.947

.024

-.021

4.53 (1.69)

8. I value my friends’/
family’s/significant
other’s opinion on
whether or not it is ok for
people without a
prescription to use the
stimulant medication for
any reason.

-.012

.954

.020

-.018

4.499
(1.695)

9. I believe the use of
stimulant medication by
people without diagnosed
ADHD, is common.

.014

-.024

-.016

.841

5.33 (1.46)

10. I believe the use of
stimulant medication by
people diagnosed with
ADHD in excess or for
purposes other than
prescribed, is common.

-.011

-.021

.092

.768

5.01 (1.46)

n = 1411.
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Finally, a factor analysis was performed on the perceived behavioral control items,
and two separate factors emerged with an eigenvalue ≥ 1. The first factor included two
indicators of perceived behavioral control [eigenvalue = 1.87, R2 = .47; α = .90]. The second
factor also included two indicators of perceived behavioral control [eigenvalue = 1.62, R2
= .41; α = .80]. See Table 12 for the factor loadings of these items. See Table 13 for means
and standard deviations of each latent construct.
Table 12.
Factor loadings for the perceived behavioral control items.
Perceived Behavioral Control Items

Factor
Loading
(Factor 1)

Factor
Loading
(Factor 2)

Mean
(SD)

1. I feel I do not need stimulant medication
to help me lose weight/control my appetite.

-.033

-.819

5.70 (1.71)

2. I am confident that I could get a stimulant
medication from someone if I wanted to.

-.905

.019

4.89 (1.93)

3. I feel I could lose weight successfully
without the help of a stimulant medication.

.034

-.812

5.74 (1.60)

-.018

4.71 (2.09)

4. I know people that would give/sell me a
-.913
prescription stimulant medication if I wanted
it.
n = 1504.
Table 13.

Means and standard deviations of the separate factors of the latent constructs.

Construct

Factor

Mean (SD)

Attitudes

1

13.25 (6.66)
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Construct

Subjective Norms

Perceived Behavioral Control

Factor

Mean (SD)

2

5.16 (2.76)

3

6.16 (3.45)

1

12.70 (5.63)

2

8.99 (3.31)

3

6.38 (4.03)

4

10.31 (2.70)

1

9.56 (3.85)

2

4.55 (3.02)

Note. n ranges from 1458-1519.
Structural equation modeling. The third aim of this study was to examine NMUPS
for weight loss and how this behavior relates to TPB constructs (latent variables), as well as
to use this model to predict membership in one of two groups: individuals who have engaged
in NMUPS for weight loss in the past year and individuals who have tried to lose weight via
other methods in the past year. Thus, the dependent variable for the SEM consisted of two
groups: 1) those reporting past year NMUPS for weight loss (and possibly other weight loss
behaviors; n = 89), and 2) those reporting trying to lose weight via other methods (and not
endorsing NMUPS for weight loss; n = 1340) in the past year. See Table 14 for frequencies
of four possible weight loss groups.
Table 14.
Original frequencies of weight loss behavior groups (past year).
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Weight Loss Behavior Group

n

%

No Weight Loss Behaviors

97

6.4

Other Weight Loss Behaviors, But No NMUPS

1340

87.8

No Other Weight Loss Behaviors, NMUPS Only

1

0.1

Other Weight Loss Behaviors and NMUPS

88

5.8

n = 1526.
A SEM with WLSMV estimation was conducted to examine the overall fit of
attitudes toward NMUPS for weight loss; social norms regarding NMUPS for weight loss;
and perceived behavioral control to lose weight without stimulants, as well as to obtain
stimulant medication, as predictors of engaging in past year NMUPS for weight loss.
Separate latent constructs were estimated for each of the TPB constructs, and were
correlated with each other in the final model. The model provided adequate overall fit to the
data (χ2 = 1273.88, df = 208, p < .001, RMSEA = .058 [90% CI = .055, .061]). Indeed, two of
the four subjective norms factors were significantly associated with NMUPS for weight loss,
indicating that those with greater subjective norms regarding knowing at least one person
who uses stimulant medication for the purpose of weight loss/appetite suppression (β = .272,
p < .001), in addition to believing that NMUPS is common (β = .196, p < .05) were more
likely to report NMUPS for weight loss. Further, both perceived behavioral control factors
were significantly associated with NMUPS for weight loss, indicating that those with lower
perceived behavioral control such that they were less likely to feel that they could lose
weight without the help of a stimulant medication (β = -.322, p < .001), as well as feeling
confident that they could obtain a stimulant medication from someone if they wanted to (β
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= .172, p < .05) were more likely to report NMUPS for weight loss. Results from the SEM
are presented in Figure 1. Additionally, the model indicated many significant correlations
among the separate factors of the three latent predictors of NMUPS. See Table 15 for
correlations.
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Figure 1. Results for the structural equation model. χ2 (208) = 1273.88, p < .001. Root Mean
Square Error of Approximation = .058. Note. All coefficients are standardized. Also, *pvalue < .001. Dotted line = not significant. Att = Attitudes. SN = Subjective Norms. PBC =
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Perceived Behavioral Control. The construct followed by an underscore and number
represents the factor number for that construct.
Table 15.
Correlations among the separate factors of the latent constructs.
Latent
Att_1
Construct

Att_2

Att_3

Norms
_1

Norms_2 Norms_3 Norms_4 PBC_1

Att_1

1

Att_2

-.39**

1

Att_3

.41**

-.22**

1

Norms_1

.49**

-.21**

.28**

1

Norms_2

-.02

.13**

-.01

-.03

1

Norms_3

.23**

-.14**

.16**

.31**

.02

1

Norms_4

.00

.33**

.04

.21**

.09**

.15**

1

PBC_1

.13**

.01

.13**

.32**

.02

.32**

.36**

1

PBC_2

-.28**

.38**

-.19**

-.16**

.12**

-.24**

.14**

.05*

PBC_2

1

Note. n ranges from 1411-1519. ** p < .001. * p < .05. Att = Attitudes. PBC = Perceived
Behavioral Control. The construct followed by an underscore and number represents the
factor number for that construct.
There were significant correlations among the three attitude factors, indicating that
those who were more likely to feel that engaging in NMUPS is ethical and safe were less
likely to be concerned that NMUPS would adversely affect a person’s health (r = -.39, p
< .001), in addition to feeling the benefits of NMUPS outweigh the potential risk (r = .41, p
< .001). Further, those who were less likely to be concerned that NMUPS would adversely
affect a person’s health were more likely to feel the benefits of NMUPS outweigh the
potential risk (r = -.22, p < .001).
There were also many significant correlations among the four subjective norms
factors, indicating that those who perceived greater social acceptability toward NMUPS were
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more likely to know at least one person who engages in NMUPS for the purpose of weight
loss/appetite suppression (r = .31, p < .001), in addition to believing NMUPS is common (r
= .21, p < .001). Those who were more likely to know at least one person who engages in
NMUPS for the purpose of weight loss/appetite suppression were also more likely to believe
NMUPS is common (r = .15, p < .001). Finally, those who were more likely to value their
friends’/ family’s / significant other’s opinion on whether or not it is okay for people to
engage in NMUPS were more likely to believe NMUPS is common (r = .09, p < .001).
There was also a significant correlation between the two PBC factors, indicating that
those who were more likely to feel that they could lose weight without the help of a stimulant
medication were also more likely to feel that they could obtain a stimulant medication if they
wanted to (r = .05, p < .05).
Further, there were many significant correlations among the separate factors of the
latent constructs. Those who were more likely to feel that engaging in NMUPS is ethical and
safe were also more likely to perceive greater social acceptability toward NMUPS (r = .49, p
< .001), in addition to knowing at least one person who engages in NMUPS for the purpose
of weight loss/appetite suppression (r = .23, p < .001). Those who were more likely to feel
that engaging in NMUPS is ethical and safe were less likely to feel that they could lose
weight without the help of a stimulant medication (r = -.28, p < .001), in addition to feeling
that they could obtain a stimulant medication if they wanted to (r = .13, p < .001).
Those who were less likely to be concerned that NMUPS would adversely affect a
person’s health were more likely to perceive greater social acceptability toward NMUPS (r =
-.21, p < .001), in addition to knowing at least one person who engages in NMUPS for the
purpose of weight loss/appetite suppression (r = -.14, p < .001). Further, those who were
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more likely to be concerned that NMUPS would adversely affect a person’s health were more
likely to value their friends’/ family’s / significant other’s opinion on whether or not it is
okay for people to engage in NMUPS (r = .13, p < .001), in addition to believing NMUPS is
common (r = .33, p < .001). Finally, those who were more likely to be concerned that
NMUPS would adversely affect a person’s health were more likely to feel that they could
lose weight successfully without the help of a stimulant medication (r = .38, p < .001).
Those who were more likely to feel the benefits of NMUPS outweigh the potential
risks were also more likely to perceive greater social acceptability toward NMUPS (r = .28, p
< .001), in addition to knowing at least one person who engages in NMUPS for the purpose
of weight loss/appetite suppression (r = .16, p < .001). Further, those who were more likely
to feel the benefits of NMUPS outweigh the potential risks were less likely to feel that they
could lose weight successfully without the help of a stimulant medication (r = -.19, p < .001),
and were more confident in feeling that they could obtain a stimulant medication if they
wanted to (r = .13, p < .001).
Those who were more likely to perceive greater social acceptability toward NMUPS
were less likely to feel that they could lose weight without the help of a stimulant medication
(r = -.16, p < .001), in addition to feeling more confident in feeling that they could obtain a
stimulant medication if they wanted to (r = .32, p < .001).
Additionally, those who were more likely to know at least one person who engages in
NMUPS for the purpose of weight loss/appetite suppression were less likely to feel that they
could lose weight without the help of a stimulant medication (r = -.24, p < .001), in addition
to feeling more confident in feeling that they could obtain a stimulant medication if they
wanted to (r = .32, p < .001).
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Those who were more likely to value their friends’/ family’s / significant other’s
opinion on whether or not it is okay for people to engage in NMUPS were more likely to feel
that they could lose weight without the help of a stimulant medication (r = .12, p < .001).
Those who were more likely to believe NMUPS is common were also more likely to
feel that they could lose weight without the help of a stimulant medication (r = .14, p < .001),
in addition to feeling more confident in feeling that they could obtain a stimulant medication
if they wanted to (r = .36, p < .001).
Fourth Aim
The MANCOVA showed a significant main effect of the three weight loss groups on
body dissatisfaction (α = .92), media influence on body image (α = .94), eating attitudes (α
= .95), and depressive symptomatology (α = .96), Pillai’s trace = .13, F (8, 2630) = 23.45, p
< .001, after controlling for gender, age, ethnicity, BMI, and education. Post hoc (Bonferroni)
analyses showed that the NMUPS/weight loss group had greater body dissatisfaction (M =
17.196, SE = .72) than both the weight loss/no NMUPS group (M = 20.94, SE = .18) and no
weight loss group (M = 24.22, SE = .68; p < .001, p < .001, respectively). (Note that lower
scores on this body image measure indicate less body satisfaction.) Similarly, the
NMUPS/weight loss group felt greater pressure from the media to have an ideal body image
(M = 24.61, SE = .89) than both the weight loss/no NMUPS group (M = 20.66, SE = .23) and
no weight loss group (M = 15.75, SE = .84; p < .001, p < .001, respectively). The
NMUPS/weight loss group had poorer eating attitudes and more eating disorder
symptomatology (M = 3.28, SE = .14) than both the weight loss/no NMUPS group (M = 1.91,
SE = .04) and no weight loss group (M = .65, SE = .14; p < .001, p < .001, respectively).
Additionally, the NMUPS/weight loss group also exhibited greater depressive
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symptomatology (M = 33.16, SE = 1.81) than both the weight loss/no NMUPS group (M =
20.85, SE = .47) and no weight loss group (M = 17.25, SE = 1.71; p < .001, p < .001,
respectively). Finally, the three groups each significantly differed from one another on each
of the constructs mentioned above except that both the weight loss/no NMUPS group and no
weight loss group reported similar rates of depressive symptomatology. See Table 16.
Table 16.
Three weight loss groups and MANCOVA constructs.
MANCOVA
Construct

Individuals
reporting
NMUPS/other
weight loss
methods (n = 77):
Mean (SE)

Individuals
reporting weight
loss methods/no
NMUPS (n =
1159): Mean (SE)

Individuals
reporting no
weight loss
methods (n = 89):
Mean (SE)

p

Body Dissatisfaction

17.196 (SE = .72)a

20.94 (SE = .18)b

24.22 (SE = .68)c

< .001

Media Influence on
Body Image

24.61 (SE = .89)a

20.66 (SE = .23)b

15.75 (SE = .84)c

< .001

Eating Attitudes

3.28 (SE = .14)a

1.91 (SE = .04)b

.65 (SE = .14)c

< .001

Depressive
Symptomatology

33.16 (SE = 1.81)a

20.85 (SE = .47)b

17.25 (SE = 1.71)b

< .001

Note. n = 1325. Lower scores on the body dissatisfaction measure indicate less body
satisfaction. Different subscript letters represent values that are significantly different.
Chi-square analyses were also performed to compare the three weight loss groups on
the following disordered eating behaviors: binge eating, vomiting, laxative use, excessive
exercising, and dietary restraint. Frequency of behaviors was categorized as either regular
occurrence (at least four times [i.e., weekly] in the past 28 days) or less than regular (no
occurrence or less than four times in the last 28 days). Approximately 50.0% of individuals
in the NMUPS/weight loss group reported regular binge eating episodes compared to 26.9%
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in the weight loss/no NMUPS group and 4.1% in the no weight loss group, χ2(2) = 48.75, p
< .001. Regular vomiting episodes also differed between the NMUPS/weight loss group
(21.3%) and the weight loss/no NMUPS group (3.7%) and the no weight loss group (1.0%),
χ2(2) = 63.43, p < .001; however, the latter two groups were not significantly different from
one another. Similarly, the NMUPS/weight loss group reported more laxative episodes
(13.5%) than the weight loss/no NMUPS group (3.3%) and the no weight loss group (1.0%),
χ2(2) = 26.25, p < .001; again, the latter two groups were not significantly different from one
another. For excessive exercise, regular occurrence was defined as “exercising in a driven or
compulsive way— as a means of controlling weight, shape or amount of fat, or to burn off
calories” at least 20 times over the past 28 days. The NMUPS/weight loss group were more
likely to report excessive exercise episodes (13.5%) than the weight loss/no NMUPS group
(5.5%) and the no weight loss group (0.0%), χ2(2) = 16.13, p < .001; the latter two groups
were not significantly different. For dietary restraint, regular occurrence was defined as
“going for long periods of time (eight hours or more) without eating anything to influence
shape or weight” greater than 12 times over the past 28 days. All three weight loss groups
were significantly different from one another, with 40.4% of the NMUPS/weight loss group
reporting regular dietary restraint, 11.3% of the weight loss/no NMUPS group reporting
restraint, and 2.1% of the no weight loss group reporting restraint, χ2(2) = 75.66, p < .001.
See Table 17.
Table 17.
Three weight loss groups and disordered eating behaviors.
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Disordered Eating Individuals
Behavior
reporting
NMUPS/other
weight loss
methods (n =
89) % reporting:

Individuals
reporting
weight loss
methods/no
NMUPS (n =
1340) %
reporting:

Individuals
reporting no
weight loss
methods (n =
97) %
reporting:

χ2

Binge Eating

49.4a

26.9b

4.1c

48.75***

Vomiting

21.3a

3.7b

1.0b

63.43***

Laxative Use

13.5a

3.3b

1.0b

26.25***

Excessive
Exercising

13.5a

5.5b

0.0b

16.13***

Dietary Restraint

40.4a

11.3b

2.1c

75.66***

Note. n = 1526. Different subscript letters represent values that are significantly different.
*** p < .001.
Chi-square analyses were also performed on the two weight loss groups to compare
differences in the engagement of other unhealthy and healthy weight loss behaviors. The no
weight loss group was excluded from these analyses (as with the SEM) given that
participants in this group reported never engaging in any of the assessed weight loss
behaviors. Because some of the variables had greater than acceptable skewness and kurtosis
scores, the PI dichotomized the weight loss behaviors into “Never Engaged” for participants
who never engaged in the behavior in the past year, and “Yes Engaged” for participants
reporting having engaged in the behavior at least rarely in the past year (i.e., “rarely” to “on a
regular basis”). The NMUPS/weight loss group had greater reporting of many of the
behaviors compared to the weight loss/no NMUPS group, including: fasting, use of diet pills,
diuretic use, using food substitutions (e.g., powder, special drink), skipping meals, smoking
cigarettes for appetite control, and watching portion sizes. See Table 18.

59

	
  
Table 18.
Two weight loss groups and unhealthy and healthy weight loss behaviors—past year.
Weight Loss Behavior

Unhealthy Behaviors
Ate very little food
Skipped meals
Fasted
Smoked more cigarettes
Took diet pills
Drank energy drinks
(e.g., Red Bull, Monster)
Used food substitute
(powder/special drink)
Followed a high
protein/low carbohydrate
diet (e.g., Atkins or other)
Used diuretics (water
pills)
Healthy Behaviors
Exercise
Ate less high-fat foods
Ate more fruits and
vegetables
Watched my portion sizes
(serving sizes)
Ate less sweets
Drank less soda pop (not
including diet soda)

Individuals reporting
NMUPS/other weight
loss methods (n =
89) % reporting:

Individuals reporting
weight loss methods/no
NMUPS (n = 1340) %
reporting:

χ2

95.5
86.4
83.0
69.7
67.0
62.9

74.4
61.4
41.3
20.4
19.1
33.9

19.896***
21.99***
58.19***
112.90***
110.66***
30.68***

60.9

34.7

24.31***

56.8

32.8

21.12***

34.8

8.0

68.33***

95.5
92.0
91.0

93.5
84.9
91.3

.54, ns
3.33, ns
.01, ns

89.9

81.1

4.30*

87.5
83.1

85.2
80.8

.36, ns
.289, ns

Note. n ranges from 1410-1427. ns = not significant. * p < .05, *** p < .001.
Finally, chi-square analyses were also conducted to compare the three weight loss
groups on other substance use. Given that many of the substance use variables were highly
skewed and kurtotic, the PI dichotomized them into “Never Engaged” for participants who
never engaged in the behavior in the past year, and “Yes Engaged” for participants reporting
having engaged in the behavior on at least 1-2 occasions in the past year (i.e., 1-2 occasions
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to 40 or more occasions). The NMUPS/weight loss group had significantly greater reporting
of all of the assessed substances compared to the other two groups. See Table 19.
Table 19.
Three weight loss groups and other substance use—past year.
Substance

Individuals
reporting
NMUPS/other
weight loss
methods (n =
89) %
reporting:

Individuals
reporting
weight loss
methods/no
NMUPS (n =
1340) %
reporting:

Individuals
reporting no
weight loss
methods (n =
97) %
reporting:

χ2

Alcohol (beer, wine,
liquor)
Marijuana (pot, weed,
hashish, hash oil)
Tobacco products
(Cigarettes, water
pipe, cigars,
smokeless tobacco)
Energy Drinks
MDMA (Ecstasy)
Cocaine (crack, rock,
freebase, powder)
Other amphetamines
(bennies)
Opiates (heroin,
smack)
Methamphetamine
(crystal meth, ice,
crank)
Anabolic steroids
(Testosterone)

95.5a

83.2b

77.3b

11.92**

89.8a

40.2b

46.4b

82.82***

83.1a

42.6b

46.4b

55.395***

78.4a
48.9a
44.9a

57.2b
7.7b
7.6b

50.5b
11.6b
11.3b

17.63***
149.96***
128.77***

39.3a

6.3b

6.2b

120.73***

30.3a

4.6b

7.3b

94.56***

28.1a

3.0b

4.2b

120.68***

13.6a

2.9b

2.1b

28.52***

Note. n ranges from 1501-1523. ns = not significant. Different subscript letters represent
values that are significantly different. ** p < .01, *** p < .001.
Discussion
The current study investigated NMUPS for weight loss in a national, young adult
sample, and assessed its relation with other problematic cognitions and health behaviors,
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including disordered eating. In addition, motivations and attitudes about NMUPS were
evaluated, as these constructs might be most amenable to change in a future intervention.
Aim 1
The first aim of this study was to examine the prevalence of NMUPS for weight loss
in a broad, national sample of young adults. Young adults, ages 18-25, were recruited
because they are the group most likely to engage in NMUPS (SAMHSA, 2012) and are also
at high risk for disordered eating behaviors (Neumark-Sztainer et al., 2011). Overall,
recruiting participants from MTurk was a relatively easy and inexpensive method, which
yielded good quality results. Given that participants were required to be within a certain age
range, reside in the U.S., and speak English, the turnaround was fairly quick at approximately
6 months for recruitment. (Additionally, recruitment time would have been quicker had there
not been errors with initial implementation.) Moreover, participants’ state residencies were
highly representative of the U.S. population, and participants were ethnically diverse,
although not quite as diverse as the national population. For example, the current sample had
lower rates of African-American and Hispanic/Latino participants compared with the
national population (U.S. Census Bureau, 2014b). Additionally, the current sample had more
females (62.6% versus 50.8%; U.S. Census Bureau, 2014b).
Approximately 12.0% of the total sample reported ever engaging in NMUPS for
weight loss, which is comparable to the rate found in a previous study among college
students (i.e., 11.7%; Jeffers et al., 2013). However, a limitation of that study included not
clearly differentiating between those who misused their own ADHD medication from those
who received medication from another source. The current study solely examined those who
engaged in non-medical use, given that prescription stimulant use may be especially harmful
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for those who do not have a prescription from a physician (Benson et al., 2015), which is
similar to the sample examined in the Jeffers & Benotsch (2014) investigation. However, the
current study’s rate of NMUPS (12.1%) is much higher than results from that study (4.4%).
Moreover, the prevalence rate for past year NMUPS for weight loss of 5.8% is higher than
the previous investigation’s lifetime rate. According to results from the current study, this
behavior had statistically significant higher rates in the Northeast region. Thus, the current
study’s prevalence rate might be higher than the rate in prior studies (i.e., Jeffers & Benotsch,
2014; Jeffers et al., 2013) given that all U.S. regions were examined (i.e., not solely Virginia
as with the previous studies), particularly the Northeast region. Higher rates of NMUPS for
weight loss in the Northeast is similar to past research that has demonstrated higher rates in
this U.S. region for rates of NMUPS, in general (Johnston, O’Malley, & Bachman, 2003;
McCabe, Knight, Teter, & Wechsler, 2005). One suggested reason for these high prevalence
rates, at least related to college students, is that many of the institutions in the Northeast have
more competitive admissions standards; thus, individuals might feel the need to use
stimulants to enhance academic performance (McCabe et al., 2005). It could also be that this
study’s prevalence rate is higher given that both college and non-college populations were
examined. Additionally, prior research has demonstrated that the most commonly endorsed
motives for NMUPS among college students are related to academics (Flory et al., 2014;
Herman-Stahl et al., 2007; Teter et al., 2006), but it could be that individuals are
underreporting stimulant use for weight loss due to a perceived stigma surrounding misusing
one’s medication or engaging in non-medical use for a less “acceptable” purpose.
For example, Lookatch, Moore, and Katz (2014) studied the impact of both gender
and motivations on college students’ perceptions of NMUPS using vignettes, which included
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either a college man or woman engaging in NMUPS for one of three motives: to get high,
study, or lose weight. They found that, regardless of gender, using a prescription stimulant as
a study aid was viewed more favorably than for the purposes of getting high or losing weight.
The authors posited that greater acceptability of using a stimulant to study might be
attributable to the similarity to the medication’s intended uses, such that individuals with
ADHD are often prescribed the medication to improve concentration and attention. Thus, an
individual without ADHD using the medication for the same purposes is seen as acceptable.
Consequently, college students may be more willing to share their experiences with NMUPS
regarding “acceptable” study motives, compared with using the medication as a weight loss
aid.
The top five reported motivations for both lifetime and past year NMUPS were: to
increase concentration, to increase energy, as a study aid, to increase alertness, and to get
high. Unsurprisingly, the majority of these motives are related to enhancing academic (or
other work-related) performance and are consistent with findings from previous research
(Teter et al., 2006). However, although weight loss/appetite suppression is not one of the
most commonly reported motives, a substantial percentage of individuals reported engaging
in this behavior over their lifetime (12.1%), over one-third of participants reporting NMUPS
reported doing so for this purpose, and of those reporting NMUPS for weight loss,
approximately half reported past year use.
Aim 2
The second aim of this study was to investigate correlates of NMUPS for weight loss,
including negative consequences associated with this misuse, age of onset, factors
influencing participants’ decision to use prescription stimulants for weight loss, knowledge

64

	
  
about these medications, medication source, and perceived effectiveness of NMUPS for
weight loss. Female and transgender participants were more likely than males to report
engaging in NMUPS for weight loss. This finding is different from prior research in which
rates were comparable among both men and women (Jeffers & Benotsch, 2014; Jeffers et al.,
2013). The current study provides evidence that, in the general young adult population,
women may be more likely to engage in this behavior, whereas, in college-only populations,
like women, men are increasingly concerned about body image and weight (Pope, Gruber,
Choi, Olivardia, & Phillips, 1997) and are not immune to engaging in unhealthy weight loss
behaviors (Petrie, Greenleaf, Reel, & Carter, 2008). Indeed, the college environment has
been implicated in the development of body dissatisfaction and disordered eating in both
women (Fitzsimmons-Craft, 2011) and men (Davila et al., 2014), and individuals may be
especially prone to seek out novel ways to lose weight. Additionally, the current study is the
first to examine such use among transgender individuals; however, it is important to note that
the sample size of transgender participants was relatively small (i.e., n = 33). White and nonWhite participants reported similar rates of the behavior. Results regarding race have been
inconsistent in prior research; rates among both Whites and non-Whites have been
comparable (Jeffers & Benotsch, 2014), and results have also demonstrated Whites are more
likely to engage in the behavior compared with non-White participants (Jeffers et al., 2013).
Thus, current results provide evidence that the racial/ethnic gap regarding weight concerns
and related behaviors is closing (Neumark-Sztainer et al., 2002). Indeed, research has shown
that among adolescents, weight-related concerns (e.g., body dissatisfaction) and behaviors
(e.g., vomiting) are prevalent irrespective of racial/ethnic background (Neumark-Sztainer et
al., 2002). Further, slightly older participants were more likely to report NMUPS for weight
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loss, compared to previous studies where age did not differ with only college student samples
(Jeffers & Benotsch, 2014; Jeffers et al., 2013). It is likely that these previous studies did not
have the power to distinguish between slight differences in age given the smaller sample
sizes. Participants reporting NMUPS for weight loss were also more likely to have a slightly
higher BMI than those who did not. Prior research has found NMUPS for weight loss to be
associated with both having a lower BMI (Jeffers & Benotsch, 2014), as well as no
differences between those reporting NMUPS for weight loss and those not reporting the
behavior (Jeffers et al., 2013). Results of the current study make sense in that NMUPS for
weight loss might be more appealing to individuals who are overweight. Thus, they may be
more willing to engage in a risky behavior to lose weight. However, it could be that in
previous research where NMUPS for weight loss was associated with a lower BMI,
individuals indeed had a lower BMI as a result of engaging in this behavior. It is also
important to note that the current sample was slightly overweight in general. Further research
should better identify which individuals are most likely to engage in this behavior, and
individuals’ perceptions of their BMI’s before and after using a stimulant for weight loss.
Additionally, participants with a high school diploma/GED or less than a high school
education were more likely to report use for weight loss compared to participants who had
completed at least one year of college/university or higher. This seems counterintuitive given
that many studies report higher rates of NMUPS among college students than their noncollege peers (Herman-Stahl et al., 2007). However, these studies typically focus on motives
related to improving school performance. It makes sense that individuals attending or who
have previously attended college would be more likely to use ADHD medications for such
motivations; whereas, losing weight is important for all types of people in the general
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population. This finding provides evidence that non-college young adults are clearly at risk
of engaging in NMUPS for weight loss.
Participants also reported a number of negative consequences associated with
NMUPS. While all participants who had ever engaged in NMUPS were asked about negative
consequences, only those who had ever engaged in NMUPS for weight loss were selected in
analyses. Thus, it is important to note that it cannot be discerned whether consequences
experienced were a result of NMUPS for weight loss, or NMUPS, in general. The top
reported consequence experienced in one’s lifetime, but not in the past year, was losing
weight or not eating properly. Approximately one-third of participants also reported that they
enjoyed using stimulants, had taken stimulants in larger amounts or over a longer period of
time than planned, felt bad physically due to stimulant use, and had done impulsive things
they later regretted. Approximately 8.0% of participants reported that they needed medical
treatment and 11.0% reported that they had to go to the ER as a consequence of NMUPS.
According to a news release from Johns Hopkins Bloomberg School of Public Health
(Johns Hopkins Bloomberg School of Public Health, 2016), a recent study found that the
number of prescriptions for Adderall has remained unchanged, but rates of non-medical use
and ER visits related to the drug have increased dramatically among young adults (Chen et
al., 2016). Such medical consequences undoubtedly have productivity and financial
implications. For example, individuals undergoing treatment are pulled away from work and
other obligations. Additionally, although there are no economic data on the abuse of
prescription stimulants, prescription opioid abuse alone costs health insurers up to $72.5
billion a year (Coalition Against Insurance Fraud, 2007). One could expect a similarly
significant financial burden given a rise in non-medical use and ER visits related to

67

	
  
prescription stimulants. Estimating this financial impact is an important gap for future
research to explore.
Past year consequences associated with NMUPS for weight loss were similar. The top
five commonly-reported consequences were the same with the exception that approximately
40.0% of participants felt guilty or ashamed due to their stimulant use, and taking stimulants
in larger amounts or over a longer period of time than planned was moved to eighth on the
list. To the PI’s knowledge, this is the first study to examine an extensive list of
consequences associated with NMUPS, particularly NMUPS for weight loss. Prior research
has demonstrated associations with NMUPS and negative consequences, including major
depressive episodes (Ali et al., 2015), but causality cannot be determined. Future research
should incorporate longitudinal studies to provide better indications of temporal precedence,
and examinations of a broad range of consequences similar to that of the current study, in
addition to examining consequences solely as a result of NMUPS for weight loss.
Participants reported that they started engaging in NMUPS for weight loss ranging
from 12 to 24 years, with a mean age of 18 years. Around 8.5% of participants reported
starting during middle school, over one-third reported starting during high school years, and
the majority reported starting at age 18 and over. It is not surprising that a substantial
minority of participants reported that they started engaging in NMUPS for weight loss during
adolescence, as adolescents are the second largest age group (following young adults) to
engage in NMUPD (SAMHSA, 2014). Moreover, NMUPS can begin as early as grade
school (Wilens et al., 2008). A systematic review examining the misuse and diversion of
medications prescribed for ADHD found that children with medications receive requests to
give, sell, or trade them to other students in elementary and high school (Wilens et al., 2008).
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Further, adolescents with stimulant prescriptions for ADHD are more likely to be approached
to divert their medications compared to individuals with prescriptions for pain, anti-anxiety,
and sleeping medications (McCabe et al., 2011).
Almost 75.0% of the participants reported that they decided to try a prescription
stimulant without a doctor’s orders specifically for the purpose of weight loss/appetite
suppressive effects due to knowing someone else who was doing it or someone else giving
his/her ADHD medication specifically for that purpose. This is not surprising given the high
rates with which ADHD medications are diverted (McCabe et al., 2011), especially from
friends and family (Jeffers et al., 2014; NIDA, 2013). Indeed, friends and family were the top
two sources of stimulant medications. Almost 20.0% heard about the idea from the media,
and the rest of the participants decided to try this behavior for other reasons not listed.
Participants also reported receiving medication from the Internet, a stranger, and other
sources. Stealing medication was reported by at least one participant who reported getting the
medication from a “teenager whose house I was watching while they were away.”
A majority of participants reported that engaging in NMUPS for weight loss was
either “mildly” or “very effective” (43.1%, 21.3%, respectively). Perceived effectiveness was
somewhat better in this study compared to prior work (Jeffers et al., 2014). Indeed, a smaller
percentage of participants reported that NMUPS for weight loss was “not at all effective.”
Future work should examine individuals’ perceptions regarding the pros and cons when
utilizing this weight loss technique.
The greatest source of exposure to information about side effects associated with the
use of ADHD medication was the Internet. This is in line with prior research demonstrating
that some of the most frequently sought topics on the Internet are related to health and
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medical information (McMullan, 2006). It is likely that the other students/friends who acted
as the next greatest sources of information were also the medication suppliers. Finally,
approximately one-third of participants reported receiving exposure to information about
ADHD medication in school.
The majority of participants reported that they considered themselves to be
knowledgeable about the side effects associated with the use of stimulant medication
normally used to treat ADHD. However, there was only a moderate correlation between
participants’ confidence in their knowledge about side effects and their actual knowledge.
The total mean score of side effects and contraindications that were answered correctly were
60.0% and 43.0%, respectively. These percentages are concerning given that individuals are
taking a medication that could negatively impact their health, especially without medical
supervision. Further, it is not clear whether individuals had this knowledge prior to engaging
in NMUPS, or whether their knowledge was a consequence of having experienced a
particular side effect (e.g., correctly identified tachycardia as a possible side effect because of
experiencing a racing heart while taking the medication). Judson and Langdon (2009) also
found that college students who engaged in illicit use without a prescription had higher
knowledge scores compared with non-users, and suggested that such knowledge primarily
results from experience.
Aim 3
The third aim of this study was to evaluate the utility of the TPB model to predict
membership in one of two groups: individuals who had engaged in NMUPS for weight loss
in the past year and individuals who had tried to lose weight via other methods in the past
year. Using items modeled after a sample TPB questionnaire (Ajzen, n.d.-a) and Judson and
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Langdon (2009), the TPB did provide adequate overall fit to the data. Although the chisquare test was statistically significant, thus indicating a poor fitting model, this fit index is
impacted by sample size and is typically significant for models with greater than 200 cases
(Kenny, 2015). Therefore, it is important to examine more than one fit index. Currently, the
most popular measure of model fit is the RMSEA (Kenny, 2015), which indicated an
adequately fitting model for the current results. Indeed, half of the subjective norms factors
and both perceived behavioral control factors were significantly associated with NMUPS for
weight loss, indicating that those with greater subjective norms regarding knowing at least
one person who uses stimulant medication for the purpose of weight loss/appetite
suppression, in addition to believing that NMUPS is common were more likely to report
NMUPS for weight loss. Further, participants reporting NMUPS for weight loss had lower
perceived behavioral control, indicating that they were more likely to agree that they do need
stimulant medication to help them lose weight/control their appetite, and that they could not
lose weight successfully without the help of a stimulant medication. Those reporting NMUPS
for weight loss also had higher perceived behavioral control regarding feeling confident that
they could obtain a stimulant medication from someone if they wanted to. Thus, the
hypothesis that “individuals who have engaged in NMUPS for weight loss will have more
favorable attitudes toward the behavior (e.g., view the behavior as ethical), view the behavior
as common, and have lower perceived behavioral control to lose weight without the help of
stimulants, as well as higher perceived behavioral control to obtain stimulant medication
compared to the other group” was partially supported.
It is interesting that attitudes was not associated with NMUPS for weight loss in the
TPB model, especially given that there were significant correlations among the three
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attitudes factors, and that many of the separate factors of the latent constructs were correlated
in their expected directions. For example, those who were more likely to feel that engaging in
NMUPS is ethical and safe were less likely to be concerned that NMUPS would adversely
affect a person’s health, in addition to feeling the benefits of NMUPS outweigh the potential
risks. Further, those who were less likely to be concerned that NMUPS would adversely
affect a person’s health were more likely to feel the benefits of NMUPS outweigh the
potential risks.
There were also significant correlations among some of the attitude and subjective
norms factors, such that those who were more likely to feel that engaging in NMUPS is
ethical and safe were also more likely to perceive greater social acceptability toward NMUPS,
in addition to knowing at least one person who engages in NMUPS for the purpose of weight
loss/appetite suppression. Those who were less likely to be concerned that NMUPS would
adversely affect a person’s health were more likely to perceive greater social acceptability
toward NMUPS, in addition to knowing at least one person who engages in NMUPS for the
purpose of weight loss/appetite suppression. Further, those who were more likely to be
concerned that NMUPS would adversely affect a person’s health were more likely to value
their friends’/ family’s / significant other’s opinion on whether or not it is okay for people to
engage in NMUPS, in addition to believing NMUPS is common. Those who were more
likely to feel the benefits of NMUPS outweigh the potential risks were also more likely to
perceive greater social acceptability toward NMUPS, in addition to knowing at least one
person who engages in NMUPS for the purpose of weight loss/appetite suppression.
Finally, there were many significant correlations among the attitudes and perceived
behavioral control factors. Those who were more likely to feel that engaging in NMUPS is
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ethical and safe were less likely to feel that they could lose weight without the help of a
stimulant medication, in addition to feeling that they could obtain a stimulant medication if
they wanted to. Those who were more likely to be concerned that NMUPS would adversely
affect a person’s health were more likely to feel that they could lose weight successfully
without the help of a stimulant medication. Further, those who were more likely to feel the
benefits of NMUPS outweigh the potential risks were less likely to feel that they could lose
weight successfully without the help of a stimulant medication, and were more confident in
feeling that they could obtain a stimulant medication if they wanted to.
The current study’s findings are slightly different from Judson and Langdon’s (2009)
results. They found that, among college students who engaged in NMUPS, results were
consistent with the TPB, such that they had fewer concerns regarding adverse health effects
and ethics of use, higher perceived positive social norms, and lower perceived behavioral
control (i.e., felt more dependent on stimulant medications). For those who misused their
own prescriptions, only social norms approached significance for predicting use.
In Gallucci’s (2011) dissertation study of undergraduates, attitudes and perceived
behavioral control were related to lifetime NMUPS; social norms, however, were not related.
His study also differs from the current study’s results, but it is important to note that the
social norm variables in the former study were associated with higher numbers of
participants who had incomplete data, and that this may have been a result of survey
administration (e.g., close proximity to friends in the classroom during survey completion),
whereas the current study provided participants complete privacy in an online environment.
Only perceived behavioral control was related to recent non-medical use (i.e., past 30 days),
which is one of the main findings Gallucci published from his dissertation (Gallucci et al.,
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2015). The authors note that non-significant relations between current NMUPS and attitudes
and subjective norms differs from Judson and Langdon’s (2009) results, but that the
inconsistencies could be attributable to differing time frames used in the studies. Gallucci et
al. examined past 30 day use, whereas Judson and Langdon examined lifetime NMUPS.
However, lower perceived behavioral control was related to NMUPS in both studies. Another
important distinction between Gallucci et al.’s study and the current study is that the former
examined individuals who engaged in both NMUPS and misuse, whereas this study
examined NMUPS only. Additionally, Judson and Langdon examined illicit use separately
among prescription and non-prescription holders and found differing results.
In Srigley’s (2013) master’s thesis, both attitude toward use and perceived behavioral
control emerged as strong predictors of intention to engage in NMUPD within the next year
in a sample of 131 college students. Srigley’s findings also differ from the current study’s
results, but inconsistencies might be attributable to such large differences in sample size,
college student sample versus national young adult sample, or that Srigley examined
intention to use, whereas the current study predicted past year use. However, it is important
to note that, as with Gallucci et al.’s (2015) study and Judson and Langdon’s (2009) study,
the current study did not measure intention to use because Ajzen (1991, 2002) claimed that
addictive behaviors have the potential to bypass intention. Thus, it can be assumed that any
participant who reported engaging in past year NMUPS for weight loss intended on doing so
(Gallucci et al., 2015).
Lastly, Ponnet and colleagues (Ponnet et al., 2015) used an extended model of the
TPB to examine Flemish college students’ intention to engage in NMUPS to enhance
academic performance. They found that subjective norms, followed by attitudes and
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perceived behavioral control predicted intention to use, among other variables (e.g.,
substance abuse).
There are a variety of factors that might contribute to the inconsistent findings among
the current study and the previous studies utilizing the TPB to predict NMUPS. Differing
time frames (e.g., lifetime, recent, past year use), differentiating between NMUPS and
misuse, large versus small sample sizes, college student samples versus national sample,
motives for use (i.e., in general, for academic purposes only, and for weight loss), and how
the constructs (i.e., attitudes, norms, perceived behavioral control) were conceptualized
might attribute to inconsistent results. Thus, it is difficult to discern whether the TPB appears
to have limited utility in predicting NMUPS due to such methodological differences, or
whether the TPB is in fact not the best model for predicting this behavior. Overall, however,
in the majority of these studies, at least some elements of the TPB significantly predict
NMUPS, the most consistent being perceived behavioral control. Findings indicate that this
TPB element might be most useful in predicting NMUPS, whether in general or for weight
loss purposes.
Aim 4
The fourth aim of this study was to compare the three groups on additional relevant
behaviors and constructs: disordered eating behaviors, body image, other substance use, and
depressive symptomatology. The NMUPS/weight loss group had greater body dissatisfaction
than both the weight loss/no NMUPS group and no weight loss group. Further, results for
body dissatisfaction were observed in expected directions among the three groups, such that
the weight loss/no NMUPS group had even greater body dissatisfaction than the no weight
loss group. Similarly, the NMUPS/weight loss group felt greater pressure from the media to
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have an ideal body image than both the weight loss/no NMUPS group and no weight loss
group; the same linear pattern was observed. These findings are consistent with past research
(Jeffers & Benotsch, 2014). However, the current study provides evidence that those
engaging in NMUPS for weight loss are even more dissatisfied with their bodies and feel
even greater pressure from the media to have an ideal body type compared with individuals
who engage in weight loss methods other than NMUPS.
The NMUPS/weight loss group had poorer eating attitudes and more eating disorder
symptomatology than the weight loss/no NMUPS group, and again, this weight loss group
had poorer eating attitudes and symptomatology than the no weight loss group. Both regular
binge eating episodes and dietary restraint were most commonly reported by individuals in
the NMUPS/weight loss group, followed by individuals in the weight loss/no NMUPS group,
followed by individuals in the no weight loss group. Regular episodes of vomiting, laxative
use, and excessive exercise were all more frequently reported in the NMUPS/weight loss
group; however, rates were similar for the weight loss/no NMUPS group and no weight loss
group. Further, the NMUPS/weight loss group had greater reporting of all of the additional
unhealthy weight loss behaviors that were assessed compared to the weight loss/no NMUPS
group: fasting, eating very little food, using diet pills, using diuretics, using food
substitutions, skipping meals, smoking more cigarettes for appetite control, following a high
protein/low carbohydrate diet (i.e., fad diet), and drinking energy drinks for appetite control.
Overall, findings are consistent with past research (Jeffers & Benotsch, 2014; Jeffers et al.,
2013). However, the current study provides evidence that those engaging in NMUPS for
weight loss have even poorer eating attitudes, are engaging in even more binge eating
episodes, and dietary restraint compared with individuals who engage in weight loss methods
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other than NMUPS. It could be that rates for regular episodes of vomiting, laxative use, and
excessive exercise were similar for the weight loss/no NMUPS group and no weight loss
groups because such low rates were reported in general among the two groups. Regardless,
individuals who engage in NMUPS for weight loss tend to endorse more unhealthy attitudes
and behaviors compared with those who utilize other weight loss techniques.
All healthy weight loss behaviors that were assessed had similar frequency rates
among the two groups, with the exception of the NMUPS/weight loss group reporting higher
frequency of watching portion sizes. This finding might make sense in that watching portion
sizes may easily lend itself into becoming an unhealthy behavior, such as eating very little
food. Given these data, it appears that individuals who engage in NMUPS for weight loss are
not simply just engaging in any and every weight loss technique (i.e., both healthy and
unhealthy strategies), but are much more likely to engage in problematic and unhealthy
weight loss strategies.
Additionally, the NMUPS/weight loss group also exhibited greater depressive
symptomatology than both the weight loss/no NMUPS group and no weight loss group.
However, the weight loss/no NMUPS group and no weight loss group reported comparable
rates of depressive symptomatology. The current findings are consistent with past research;
NMUPD has been associated with poor mental health, including depressive symptoms,
suicidality, and anxiety among college students (Dussault & Weyandt, 2013; Zullig & Divin,
2012). Ali et al. (2015) also found a positive relation between NMUPD and major depressive
episodes among adolescents.
Finally, the NMUPS/weight loss group had significantly greater reporting of all of the
assessed substances compared to the other two groups, which reported comparable substance
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use rates. Indeed, the NMUPS/weight loss group reported surprisingly high rates for many of
the substances, including: marijuana (89.8%, almost double that of the other two groups),
cocaine (44.9%, approximately four-times that of the other groups), and ecstasy (48.9%,
approximately four-times that of the other groups). This is similar to prior research in which
college students who reported NMUPS for weight loss were more likely to report using illicit
drugs but not alcohol over the past 3 months compared to non-users (Jeffers & Benotsch,
2014); although, in the current study, users were more likely to report alcohol use compared
with non-users. Additionally, NMUPS has been associated with other substance use
including use of alcohol, tobacco, marijuana, cocaine, and ecstasy (Lanier & Farley, 2011).
NMUPS is also associated with past year alcohol or drug use disorders in both males and
females (Wu et al., 2007).
Data from this national sample demonstrates that individuals who are engaging in
stimulant use for weight loss are also highly more likely to use many other substances. Future
research should examine whether ADHD medication facilitates more as a gateway drug, or if
other substance use precipitates using ADHD medication non-medically. In one longitudinal
study of college students, energy drink users consumed more alcohol and were more likely to
have used other drugs, both in the same year and in the preceding year (Arria et al., 2010).
Results demonstrated that Year 2 energy drink use was significantly associated with Year 3
NMUPS and non-medical use of prescription analgesics, but was not associated with other
drug use in Year 3. Additionally, Woolsey et al. (2015) found that energy drink use
frequency was a significant predictor of NMUPS. Using data from the same longitudinal
study mentioned above, Arria et al. (2013) found that as cannabis and alcohol use increased,
college students experienced associated increases in skipping class and decreases in GPA,

78

	
  
which in turn led to a higher likelihood of engaging in NMUPS for study purposes. Data
from national samples have demonstrated that NMUPD is a risk factor for future drug
dependence (Schepis & Krishnan-Sarin, 2008), binge drinking (McCauley et al., 2011), and
substance use disorders (Schepis & Hakes, 2011). Additional longitudinal work is needed to
disentangle which substance comes first, and whether this is dependent upon motive (e.g.,
energy drink use leads to NMUPS for study aid purposes, NMUPS leads to cocaine use for
getting high purposes). Moreover, future work should determine if individuals engaging in
NMUPS for weight loss are using some of these drugs simultaneously.
The hypothesis that “the three groups will differ on various constructs, such that
individuals who engage in NMUPS for weight loss will have poorer body image, higher rates
of disordered eating, higher rates of other substance use, and greater depressive
symptomatology compared to the other two groups” was fully supported.
Limitations and Strengths
Limitations of this study should be considered when interpreting findings. All
measures were based on self-report, which may have resulted in biases or errors in reporting.
For example, BMI was calculated based on self-reported weight and height; thus, data
analyses regarding BMI might have been slightly inaccurate. However, prior research has
demonstrated that web-based self-reports of height and weight are moderately to highly
correlated with actual height and weight, and suggest that online self-reported measurements
can be a valid method of data collection (Bonn, Lagerros, & Bälter, 2013; Pursey, Burrows,
Stanwell, & Collins, 2014). Similarly, the online nature of the study did not allow for a
controlled testing environment, such as preventing or controlling for outside distractions.
Further, there may have been a response bias as participants self-selected to participate in a
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study titled “Substance use, eating behaviors, mental health, and weight loss.” Such selfselection might impact the generalizability of results to the overall population. Further, an
Internet sample might not be representative of the general population. For example, MTurk
workers tend to be more educated than the general U.S. population, which may reflect higher
education levels among technology users (Paolacci et al., 2010). MTurk samples also have a
large proportion of both White and female participants, which is comparable to
characteristics of other Internet samples (Casler et al., 2013; Shapiro et al., 2013). Indeed, the
current sample also had a larger proportion of females compared with the national
population; however, this is not atypical of many psychological studies. Additionally, the
observational design limits interpretations of causality.
Despite limitations, this study had numerous strengths. To the PI’s knowledge, this is
the first study to examine NMUPS for weight loss in a national sample of young adults, as
well as the first to examine this behavior in both participants attending college and those not
attending college. Further, there was a large correlation between participants’ state
residencies and the U.S. population, and participants were fairly ethnically diverse. This is
also the first study to apply a theoretical model when examining NMUPS for weight loss.
Further, using SEM allowed for the estimation of latent variables, thus eliminating random
error (Hays et al., 2005). The current study also provides additional evidence regarding prior
inconsistent results for “building a profile” of the typical NMUPS for weight loss user,
including supporting higher rates among females and similar rates among White and nonWhite participants. This is also the first study to examine such use among transgender
individuals (who, along with female participants, were more likely to report this behavior
compared with males). However, it is important to note that this sample included a small

80

	
  
percentage of transgender participants and findings are preliminary. To the PI’s knowledge,
this is the first study to examine an extensive list of consequences associated with NMUPS.
This is also one of the first studies to indicate that many individuals begin NMUPS for
weight loss during adolescence.
Implications and Future Directions
This study provides evidence that a large percentage of young adults are engaging in
NMUPS (approximately one-third), and a substantial minority of individuals are engaging in
NMUPS for weight loss (approximately 12.0%). Many of these young adults also report a
variety of negative consequences associated with this use. Future research should utilize
longitudinal designs and examine how subsequent use is related to such consequences (e.g.,
continuing use despite a trip to the ER as a result of NMUPS), in addition to examining
consequences resulting solely as a function of NMUPS for weight loss. Additionally, future
research should examine individuals’ perceptions regarding the pros and cons when utilizing
this weight loss technique, and why they feel the “need” to use stimulants to lose weight.
Further, additional work should examine this behavior among transgender individuals given
the high rate found in this study.
Investigation into NMUPS for weight loss in adolescents is also needed, as current
results suggest this behavior often begins during this developmental stage. Further, prior
research provides evidence that NMUPD frequently begins during adolescence (Wilens et al.,
2008; Young, Glover, & Havens, 2012). The relation between NMUPD and other substance
use also begins in adolescence (Nakawaki & Crano, 2012; Young et al., 2012). Moreover,
adolescence is a common time for the onset of many eating disorder symptoms and unhealthy
weight control behaviors (Hoste, Labuschagne, & Le Grange, 2012; Neumark-Sztainer et al.,
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2011; Rawana, Morgan, Nguyen, & Craig, 2010; Vander Wal, 2012). Only one study has
examined motivations for NMUPD in a nationally representative sample of high school
seniors, and prescription stimulants were the largest class of non-medically used drugs
(McCabe & Cranford, 2012). Notably, 35.5% of individuals who reported NMUPS indicated
doing so to help with weight loss.
The current study clearly provides evidence that non-college young adults are at risk
of engaging in NMUPS, and for weight loss in particular. Given the finding that participants
with a high school diploma/GED or less than a high school education were more likely to
report use compared to participants who had completed at least one year of college/university
or higher, future investigations should better elucidate NMUPS for weight loss rates, and
other motives (e.g., academic) among different educational groups. For example, future work
might compare/contrast non-college individuals, individuals currently attending college, and
those who have graduated college. Further, as with Lookatch et al.’s study (2014), it could be
useful to examine how stigma surrounding certain motives might also play a role.
Despite the finding that attitudes were not significant in the final SEM, the TPB did
provide an adequate overall fit to the data. Two of the four subjective norms factors and both
perceived behavioral control factors were significantly associated with NMUPS for weight
loss, and many of the separate factors of the latent constructs were significantly correlated
with each other in expected directions; thus, the TPB could provide useful information when
examining NMUPS for weight loss in future samples. Additionally, current results and prior
studies provide evidence that perceived behavioral control significantly predicts NMUPS,
and might be most useful in predicting NMUPS, whether in general or for weight loss
purposes.
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Future investigations should also examine misuse of prescription stimulants for
weight loss in a national sample, the utility of the TPB to predict this behavior, in addition to
other correlates examined in the current study. It would be interesting to see whether findings
differ depending on whether one engages in non-medical use, misuses one’s own prescription,
or if engaging in both of these behaviors yields different results. Future longitudinal research
should examine whether ADHD medication facilitates as a gateway drug, or if other
substance use precipitates misusing one’s ADHD medication, or using non-medically.
Additionally, future qualitative work may aid in the exploration of this research and
gain a complex, detailed understanding of the issue. In particular, it is important to capture
the “essence” of the behavior by understanding experiences of NMUPS for weight loss and
the context and situations that influence the behavior. Additionally, answers that are not
easily captured in quantitative surveys (or are limited in their response), such as the
advantages/disadvantages to losing weight this way, situations that promote this behavior,
and perhaps instances of polysubstance use would benefit from qualitative inquiry. Moreover,
qualitative methodology has typically been neglected in past NMUPD research (DeSantis et
al., 2008), and especially with regard to NMUPS for weight loss.
Eating disorder prevention and intervention programs would benefit from assessing
NMUPS for weight loss and educating young adults about associated dangers. Clinicians
should also include this behavior when assessing unhealthy weight loss practices given that
many of the individuals who have engaged in NMUPS for weight loss have also engaged in
better known problematic ways to lose weight. Approximately 67.0%, 35.0%, 21.0%, and
14.0% of participants reporting this behavior also took diet pills, used diuretics, vomited to
lose weight, and used laxatives, respectively. When prescribing ADHD medications,

83

	
  
physicians should emphasize the harmful consequences associated with sharing prescriptions
and taking medications for purposes other than intended. Quality education concerning side
effects and contraindications is especially important given such disconcertingly low rates
regarding medication knowledge. NMUPD awareness campaigns should include information
regarding NMUPS for weight loss and negative health consequences.
Programs and interventions focused on preventing or reducing NMUPS for weight
loss could address beliefs about use and other motives. Because there are a variety of motives
associated with NMUPS and many individuals endorse more than one motive, interventions
might benefit from shining light on these other motives. Messages framed to suggest that
despite the perception that non-medical use might seem socially acceptable, but is indeed
illegal, unethical, and unsafe might be beneficial. An additional component might include
providing anecdotal and/or statistical evidence of negative consequences including ER visits
(e.g., 10.9%), feeling bad physically (e.g., 27.1%), and doing impulsive things that are
subsequently regretted (e.g., 26.9%). Moreover, given that non-medical users were more
likely to perceive that they “needed” stimulant medication to aid in successful weight loss,
methods aimed at increasing perceived behavioral control regarding stimulant use and weight
loss could be a particularly essential component in an intervention. Further, methods aimed at
changing perceptions surrounding subjective norms regarding the belief that NMUPS is
common would be useful.
Emphasizing healthful and sustaining weight loss strategies, while simultaneously
underscoring negative consequences associated with use and the harms of taking a
prescription without supervision for unintended purposes could be beneficial. Further, given
that almost half of individuals reporting NMUPS for weight loss in the past year reported
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engaging in regular binge eating episodes in the past 28 days, specific techniques to deal with
binge eating should be addressed. Techniques might include focusing on positive cognitiveemotional coping skills, such as identifying potential stressors related to bingeing and
brainstorming steps to deal with them (Kelly, Lydecker, & Mazzeo, 2012). Additionally, a
key component of binge eating disorder is the sense of loss of control that accompanies a
binge episode, which is similar to the loss of control that is associated with substance use
disorders (Reese, Pollert, & Veilleux, 2016). This feature is one such commonality that has
led researchers to conceptualize binge eating disorder as an addictive-spectrum disorder, like
substance use disorders (Schreiber, Odlaug, & Grant, 2013). Thus, increasing self-control,
and specifically addressing the perspective that self-control, or willpower, is a limited
resource might be beneficial in reducing bingeing and substance use behavior (Reese et al.,
2016)—which seems applicable to an intervention targeting NMUPS for weight loss.
Interventions might also benefit from incorporating components to improve mental
health, particularly related to body image and depressive symptomatology. Body
dissatisfaction may be especially important to highlight in relation to perceived pressures
from the media, which have become increasingly focused on the thin-ideal for women and
muscularity for men (Leit, Pope, & Gray, 2001; Mazur, 1986). Interventions should
emphasize how such media images are often unrealistic (Heinberg, Thompson, & Stormer,
1995). Increasing body appreciation may be worthwhile as this has been suggested to be an
easier feat than attempting to decrease levels of body dissatisfaction (Andrew, Tiggemann, &
Clark, 2014; Andrew, Tiggemann, & Clark, 2015). Strategies might include encouraging
activities that emphasize the function, rather than the appearance, of the body, such as yoga
and other athletics (Andrew et al., 2015; Menzel & Levine, 2011; Tylka, 2012). Interventions
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should also include a screen for depression, in addition to coping techniques and counseling
referrals. Further, given such high rates of additional substance use, interventions aimed at
reducing other substance use, and educating about the harms associated with mixing
substances and polysubstance use might result in a reduction of the behavior. Education
surrounding seemingly harmless substances including energy drinks, as well as more wellknown harmful agents such as marijuana, cocaine, and methamphetamine should be
incorporated.
Conclusion
A substantial minority of young adults are obtaining prescription stimulant
medication for the appetite suppression and weight loss effects. Research has demonstrated
that this non-medical use is related to disordered eating behaviors; other substance use; and
psychological concerns, including body dissatisfaction and depressive symptomatology.
Moreover, individuals who engage in NMUPS for weight loss tend to endorse more
unhealthy attitudes and behaviors compared with those who utilize other weight loss
techniques. NMUPS for weight loss is also associated with a variety of negative
consequences and users are not well-informed regarding stimulant medication knowledge.
While there have been mixed results concerning who engages in this behavior, prescription
stimulants may be more appealing to women and transgender individuals (although men are
not immune from engaging in this behavior), as well as both White and non-White
individuals. Prospective research is needed to further examine this behavior in other
populations (e.g., adolescents), utilizing various methodologies (e.g., qualitative inquiry), and
longitudinal investigation. This study extends the literature on the utility of the TPB in
examining NMUPS, and provides the first research on utilizing the TPB to examine NMUPS
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for weight loss. Findings demonstrate that methods aimed at increasing perceived behavioral
control regarding stimulant use and weight loss, and changing perceptions surrounding
subjective norms could be particularly essential components in an intervention. Emphasizing
healthful and sustaining weight loss strategies, improving mental health, educating about
polysubstance use, and underscoring negative consequences associated with use are other
potential intervention targets.

87

	
  

List of References
Adderall XR. (2014). Retrieved from http://www.pdr.net/drug-summary/adderallxr?druglabelid=534&id=1810
Ajzen, I. (1991). The Theory of Planned Behavior. Organizational Behavior and Human
Decision Processes, 50, 179-211.
Ajzen, I. (2002). Perceived behavioral control, self-efficacy, locus of control, and the Theory
of Planned Behavior. Journal of Applied Social Psychology, 32(4), 665-683.
Ajzen, I. (n.d.-a). Sample TPB Questionnaire. Retrieved from
http://people.umass.edu/aizen/pdf/tpb.questionnaire.pdf
Ajzen, I. (n.d.-b). Constructing a Theory of Planned Behavior Questionnaire. Retrieved from
http://people.umass.edu/aizen/pdf/tpb.measurement.pdf
Ali, M. M., Dean, D., Lipari, R., Dowd, W. N., Aldridge, A. P., & Novak, S. P. (2015). The
mental health consequences of nonmedical prescription drug use among adolescents.
Journal of Mental Health Policy and Economics, 18(1), 3-15.
Andrew, R., Tiggemann, M., & Clark, L. (2014). Positive body image and young women’s
health: Implications for sun protection, cancer screening, weight loss and alcohol
consumption behaviours. Journal of Health Psychology, 1–12. http://
dx.doi.org/10.1177/1359105314520814
Andrew, R., Tiggemann, M., & Clark, L. (2015). The protective role of body appreciation
against media-induced body dissatisfaction. Body Image, 15, 98-104.
http://dx.doi.org/10.1016/j.bodyim.2015.07.005
Arria, A. M., Caldeira, K. M., Kasperski, S. J., O’Grady, K. E., Vincent, K. B., Griffiths, R.
R., & Wish, E. D. (2010). Increased alcohol consumption, nonmedical prescription
drug use, and illicit drug use are associated with energy drink consumption among
college students. Journal of Addiction Medicine, 4(2), 74-80.

88

	
  
Arria, A. M., & DuPont, R. L. (2010). Nonmedical prescription stimulant use among college
students: Why we need to do something and what we need to do. Journal of Addictive
Diseases, 29, 417-426 doi: 10.1080/10550887.2010.509273
Arria, A. M., Wilcox, H. C., Caldeira, K. M., Vincent, K. B., Garnier-Dykstra, L. M., &
O’Grady, K. E. (2013). Dispelling the myth of “smart drugs”: Cannabis and alcohol
use problems predict nonmedical use of prescription stimulants for studying.
Addictive Behaviors, 38, 1643-1650. http://dx.doi.org/10.1016/j.addbeh.2012.10.002
Benotsch, E. G., Koester, S., Luckman, D., Martin, A., & Cejka, A. (2011). Non-medical use
of prescription drugs and sexual risk behavior in young adults. Addictive Behaviors,
36, 152-155.
Benotsch, E. G., Perschbacher Lance, S., Nettles, C. D., & Koester, S. (2012). Attitudes
towards methamphetamine use and HIV risk behavior in men who have sex with men.
The American Journal on Addictions, 21((Suppl 1)), S35-S42.
Benson, K., Flory, K., Humphreys, K. L., & Lee, S. S. (2015). Misuse of stimulant
medication among college students: A comprehensive review and meta-analysis.
Clinical Child and Family Psychology Review, 18, 50-76. doi: 10.1007/s10567-0140177-z
Bernstein, E. (2006). A new breed of ‘diet’ pills. Wall Street Journal. Retrieved from
http://www.wsj.com/articles/SB115620617571041689
Blanchard, K. A., Morgenstern, J., Morgan, T. J., Lobouvie, E. W., & Bux, D. A. (2003).
Assessing consequences of substance use: psychometric properties of the inventory of
drug use consequences. Psychology of Addictive Behaviors, 17(4), 328-331. doi:
10.1037/0893-164X.17.4.328
Brown, T. A., Cash, T. F., & Mikulka, P. J. (1990). Attitudinal body image assessment:
Factor analysis of the Body-Self Relations Questionnaire. Journal of Personality
Assessment, 55, 135–144.
Buhrmester, M., Kwang, T., & Gosling, S. (2011). Amazon’s Mechanical Turk: A new
source of inexpensive, yet high- quality, data? Perspectives on Psychological Science,
6, 3-5.
Bonn, S. E., Lagerros, Y. T., & Bälter, K. (2013). How valid are web-based self-reports of
weight? Journal of Medical Internet Research, 15(4): e52. doi: 10.2196/jmir.2393
89

	
  
Cash, T. F., Morrow, J. A., Hrabosky, J. I., & Perry, A. A. (2004). How has body image
changed? A cross-sectional investigation of college women and men from 1983 to
2001. Journal of Consulting and Clinical Psychology, 72(6), 1081-1089. doi:
10.1037/0022-006X.72.6.1081
Casler, K., Bickel, L., & Hackett, E. (2013). Separate but equal? A comparison of
participants and data gathered via Amazon’s MTurk, social media, and face-to-face
behavioral testing. Computers in Human Behavior, 29(6), 2156-2160. doi:
10.1016/j.chb.2013.05.009
Chen, L. Y., Crum, R. M., Strain, E. C., Alexander, G. C., Kaufmann, C., & Mojtabai, R.
(2016). Prescriptions, nonmedical use, and emergency department visits involving
prescription stimulants. The Journal of Clinical Psychiatry. Advance online
publication.
Coalition Against Insurance Fraud. (2007). Prescription for peril: How insurance fraud
finances theft and abuse of addictive prescription drugs. Retrieved from
http://www.insurancefraud.org/downloads/drugDiversion.pdf
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Hillsdale,
New Jersey: Lawrence Erlbaum Associates, Inc.
Collins, S. E., & Carey, K. B. (2007). The theory of planned behavior as a model of heavy
episodic drinking among college students. Psychology of Addictive Behaviors, 21(4),
498-507. doi: 10.1037/0893-164X.21.4.498
Conner, M., Kirk, S. F., Cade, J. E., & Barrett, J. H. (2003). Environmental influences:
Factors influencing a woman’s decision to use dietary supplements. Journal of
Nutrition, 133(6), 1978S-1982S.
Davila, E. P., Kolodziejczyk, J. K., Norman, G. J., Calfas, K., Huang, J. S. Rock, C. L.,
…Patrick, L. (2014). Relationships between depression, gender, and unhealthy weight
loss practices among overweight or obese college students. Eating Behaviors, 15,
271-274. http://dx.doi.org/10.1016/j.eatbeh.2014.03.010
Des Jarlais, D. C., Paone, D., Milliken, J., Turner, C. F., Miller, H., Gribble, J., . . . Friedman,
S. (1999). Audio-computer interviewing to measure risk behaviour for HIV among
injecting drug users: A quasi-randomised trial. Lancet, 353, 1657-1661.

90

	
  
DeSantis, A. D., Webb, E. M., & Noar, S. M. (2008). Illicit use of prescription ADHD
medications on a college campus: a multimethodological approach. Journal of
American College Health, 57(3), 315-324. doi: 10.3200/JACH.57.3.315-324
Dussault, C. L., & Weyandt, L. L. (2013). An examination of prescription stimulant misuse
and psychological variables among sorority and fraternity college populations.
Journal of Attention Disorders, 17(2), 87-97. doi: 10.1177/1087054711428740
Eaton, W. W., Muntaner, C., Smith, C., Tien, A., & Ybarra, M. (2004). Center for
epidemiologic studies depression scale: Review and revision (CESD and CESD-R)
(In: Maruish ME, ed.). Mahwah NJ: Lawrence Erlbaum.
Fairburn, C. G., & Beglin, S. J. (1994). Assessment of eating disorders: Interview or selfreport questionnaire. International Journal of Eating Disorders, 16, 363-370.
Fitzsimmons-Craft, E. E. (2011). Social psychological theories of disordered eating in
college women: Review and integration. Clinical Psychology Review, 31(7), 1224–
1237.
Flory, K., Payne, R. A., & Benson, K. (2014). Misuse of prescription stimulant medication
among college students: Summary	
 of the research literature and clinical
recommendations. Journal of Clinical Outcomes Management, 21(12), 559-568.
Gallucci, A., Martin, R., Beaujean, A., & Usdan, S. (2015). An examination of the misuse of
prescription stimulants among college students using the theory of planned behavior.
Psychology, Health & Medicine, 20(2), 217-226. doi:
10.1080/13548506.2014.913800
Gallucci, A. R. (2011). A survey examining the nonmedical use and diversion of prescription
stimulant medications among college students using the Theory of Planned Behavior.
(Doctoral dissertation), The University of Alabama. Retrieved from
http://acumen.lib.ua.edu/content/u0015/0000001/0000552/u0015_0000001_0000552.
pdf
Gardner, R. M., Brown, D. L., & Boice, R. (2012). Using Amazon's Mechanical Turk
website to measure accuracy of body size estimation and body dissatisfaction. Body
Image, 9(4), 532-534. doi: 10.1016/j.bodyim.2012.06.006

91

	
  
Gardner, R. M., Jappe, L. M., & Gardner, L. (2009). Development and validation of a new
figural drawing scale for body image assessment: The BIAS-BD. Journal of Clinical
Psychology, 65, 113–122.
Gosling, S. D., Vazire, S., Srivstava, S., & John, O. P. (2004). Should we trust web-based
studies? A comparative analysis of six preconceptions about Internet questionnaires.
American Psychologist, 59, 93-104.
Hays, R. D., Revicki, D., & Coyne, K. S. (2005). Application of structural equation modeling
to health outcomes research. Evaluation and the Health Professions, 28(3), 295-309.
doi: 10.1177/0163278705278277
Heinberg, L. J., Thompson, J. K., & Stormer, S. (1995). Development and validation of the
Sociocultural Attitudes Towards Appearance Questionnaire. International Journal of
Eating Disorders, 17(1), 81-89.
Herman-Stahl, M. A., Krebs, C. P., Kroutil, L. A., & Heller, D. C. (2007). Risk and
protective factors for methamphetamine use and nonmedical use of prescription
stimulants among young adults aged 18 to 25. Addictive Behaviors, 32(5), 1003-1015.
doi: 10.1016/j.addbeh.2006.07.010
Higher Education Center. (2012). Prescription stimulants: Ritalin, Adderall, Concerta,
Dexedrine. Retrieved from http://www.higheredcenter.org/high-risk/drugs/ritalin
Hoste, R. R., Labuschagne, Z., & Le Grange, D. (2012). Adolescent bulimia nervosa.
Current Psychiatry Reports, 14(4), 391-397.
Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure
analysis: Conventional criteria versus new alternatives. Structural Equation Modeling,
6(1), 1-55.
Institute for Behavior and Health. (n.d). Prescription Drug Abuse. Retrieved from
http://www.ibhinc.org/pda.html
Ipeirotis, P. G. (2010). Demographics of Mechanical Turk. CeDER-10--01 working paper.
New York University.

92

	
  
Jeffers, A., Benotsch, E. G., & Koester, S. (2013). Misuse of prescription stimulants for
weight loss, psychosocial variables, and eating disordered behaviors. Appetite, 65, 813. doi: 10.1016/j.appet.2013.01.008
Jeffers, A. J., & Benotsch, E. G. (2014). Non-medical use of prescription stimulants for
weight loss, disordered eating, and body image. Eating Behaviors, 15(3), 414-418.
doi:10.1016/j.eatbeh.2014.04.019
Jeffers, A. J., Vatalaro-Hill, K., & Benotsch, E. G. (2014). Energy drinks, weight loss, and
mental health. Journal of American College Health, 62(5), 336-342.
doi:10.1080/07448481.2014.902838
Johns Hopkins Bloomberg School of Public Health. (2016). Adderall misuse rising among
young adults [News release]. Retrieved from http://www.jhsph.edu/news/newsreleases/2016/adderall-misuse-rising-among-young-adults.html
Johnson, C. (2006). Off-label drugs prescribed for weight loss. CBS News. Retrieved from:
http://www.cbsnews.com/news/off-label-drugs-prescribed-for-weight-loss/
Johnston, L. D., O’Malley, P. M. & Bachman, J. G. (2003). Monitoring the Future National
Survey Results on Drug Use, 1975– 2002: II. College Students and Adults Ages 19–
40. NIH publication no. 03–5376. Washington, DC: US Department of Health and
Human Services.
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2013). Monitoring
the Future National Survey Results on Drug Use, 1975-2012: Volume 2, College
Students and Adults Ages 19-50. Ann Arbor: Institute for Social Research, The
University of Michigan.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2005). Monitoring
the Future National Survey Results on Drug Use, 1975–2004: Volume 1, Secondary
School Students. Bethesda, MD: National Institute on Drug Abuse.
Judson, R., & Langdon, S. W. (2009). Illicit use of prescription stimulants among college
students: prescription status, motives, theory of planned behaviour, knowledge and
self-diagnostic tendencies. Psychology, Health & Medicine, 14(1), 97-104. doi:
10.1080/13548500802126723
Karazsia, B. T., & Crowther, J. H. (2008). Psychological and behavioral correlates of the
SATAQ-3 with males. Body Image, 5(1), 109-115. doi:
10.1016/j.bodyim.2007.08.004
93

	
  
Kelly, B. C., Wells, B. E., Leclair, A., Tracy, D., Parsons, J. T., & Golub, S. A. (2013).
Prevalence and correlates of prescription drug misuse among socially active young
adults. International Journal of Drug Policy, 24(4), 297-303. doi:
10.1016/j.drugpo.2012.09.002
Kelly, N. R., Lydecker, J. A., & Mazzeo, S. E. (2012). Positive cognitive coping strategies
and binge eating in college women. Eating Behaviors, 13, 289-292.
doi:10.1016/j.eatbeh.2012.03.012
Kenny, D. A. (2015, November 24). Measuring model fit. Retrieved from
http://davidakenny.net/cm/fit.htm
Kent, J. D., Blader, J. C., Koplewicz, H. S., Abikoff, H., & Foley, C. A. (1995). Effects of
late-afternoon methylphenidate administration on behavior and sleep in attentiondeficit hyperactivity disorder. Pediatrics, 96(2), 320-325.
Lanier, C., & Farley, E. J. (2011). What matters most? Assessing the influence of
demographic characteristics, college-specific risk factors, and poly-drug use on
nonmedical prescription drug use. Journal of American College Health, 59(8), 721727. doi: 10.1080/07448481.2010.546463
Lavender, J. M., De Young, K. P., & Anderson, D. A. (2010). Eating Disorder Examination
Questionnaire (EDE-Q): norms for undergraduate men. Eat Behav, 11(2), 119-121.
doi: 10.1016/j.eatbeh.2009.09.005
Leit, R. A., Pope, H. G., & Gray, J. J. (2001). Cultural expectations of muscularity in men:
The evolution of Playgirl centerfolds. International Journal of Eating Disorders, 29,
90-93.
Lookatch, S. J., Moore, T. M., & Katz, E. C. (2014). Effects of gender and motivations on
perceptions of nonmedical use of prescription stimulants. Journal of American
College Health, 62(4), 255-262. doi: 10.1080/07448481.2014.891593
Mason, W., & Suri, S. (2012). Conducting behavioral research on Amazon’s Mechanical
Turk. Behavior Research Methods, 44, 1-23. doi: 10.3758/s13428-011-0124-6
Mason, W. A., & Watts, D. J. (2009). Financial incentives and the performance of crowds.
Paper presented at the ACM SIGKDD Workshop on Human Computation, New
York: ACM.

94

	
  
Mazur, A. (1986). U.S. trends in feminine beauty and overadaptation. Journal of Sex
Research, 22, 281-303.
McCabe, S. E., & Cranford, J. A. (2012). Motivational subtypes of nonmedical use of
prescription medications: results from a national study. Journal of Adolescent Health,
51(5), 445-452. doi: 10.1016/j.jadohealth.2012.02.004
McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005). Non-medical use of
prescription stimulants among US college students: Prevalence and correlates from a
national survey. Addiction, 99, 96-106. doi: 10.1111/j.1360-0443.2004.00944.x
McCabe, S. E., & Teter, C. J. (2007). Drug use related problems among nonmedical users of
prescription stimulants: A web-based survey of college students from a Midwestern
university. Drug and Alcohol Dependence, 91, 69-76. doi:
0.1016/j.drugalcdep.2007.05.010
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006). Medical use, illicit use and diversion of
prescription stimulant medication. Journal of Psychoactive Drugs, 38(1), 43-56.
McCabe, S. E., West, B. T., Cranford, J. A., Ross-Durow, P., Young, A., Teter, C. J., &
Boyd, C. J. (2011). Medical misuse of controlled medications among adolescents.
Archives of Pediatrics and Adolescent Medicine, 165(8), 729-735.
McCauley, J. L., Amstadter, A. B., Macdonald, A., Kmett Danielson, C., Ruggiero, K. J.,
Resnick, H. S., & Kilpatrick, D. G. (2011). Non-medical use of prescription drugs in
a national sample of college women. Addictive Behaviors, 36, 690–695.
McMullan, M. (2006). Patients using the Internet to obtain health information: How this
affects the patient-health professional relationship. Patient Education and Counseling,
63, 24-28. doi:10.1016/j.pec.2005.10.006
Menzel, J. E., & Levine, M. P. (2011). Embodying experiences and the promotion of positive
body image: The example of competitive athletics. In R. M. Calogero, S. TantleffDunn & J. K. Thompson (Eds.), Self-objectification in women: Causes, consequences,
and counteractions (pp. 163–186). Washington, DC: American Psy- chological
Association.
Miller, W. R., Tonigan, J. S., & Longabaugh, R. (1995). The Drinker Inventory of
Consequences (DrInC): An instrument for assessing adverse consequences of alcohol

95

	
  
abuse. Test manual (Project MATCH Monograph Series, Vol. 4). Rockville, MD:
National Institute on Alcohol Abuse and Alcoholism.
Morrison, D. M., Lohr, M. J., Beadnell, B. A., Gillmore, M. R., Lewis, S., & Gilchrist, L.
(2010). Young mothers' decisions to use marijuana: a test of an expanded Theory of
Planned Behaviour. Psychology & Health, 25(5), 569-587. doi:
10.1080/08870440902777554
Nakawaki, B., & Crano, W. D. (2012). Predicting adolescents' persistence, non-persistence,
and recent onset of nonmedical use of opioids and stimulants. Addictive Behaviors,
37(6), 716-721.
National Institute on Drug Abuse. (2009). DrugFacts: Stimulant ADHD Medications Methylphenidate and Amphetamines. Retrieved from
http://www.drugabuse.gov/publications/drugfacts/stimulant-adhd-medicationsmethylphenidate-amphetamines
National Institute on Drug Abuse. (2013). DrugFacts: Prescription and Over-the-Counter
Medications. Retrieved from
http://www.drugabuse.gov/publications/drugfacts/prescription-over-countermedications
Neumark-Sztainer, D., Wall, M., Larson, N. I., Eisenberg, M. E., & Loth, K. (2011). Dieting
and disordered eating behaviors from adolescence to young adulthood: findings from
a 10-year longitudinal study. Journal of the American Dietetic Association, 111(7),
1004-1011. doi: 10.1016/j.jada.2011.04.012
Nguyen, M. N., Potvin, L., & Otis, J. (1997). Regular exercise in 30- to 60- year old men:
Combining the stages-of-change model and the theory of planned behavior to identify
determinants for targeting heart health interventions. Journal of Community Health,
22, 233-247.
Palmer, R. S., McMahon, T. J., Moreggi, D. I., Rounsaville, B. J., & Ball, S. A. (2012).
College Student Drug Use: Patterns, Concerns, Consequences, and Interest in
Intervention. J Coll Stud Dev, 53(1), 124-132. doi: 10.1353/csd.2012.0014
Paolacci, G., Chandler, J., & Ipeirotis, P. G. (2010). Running experiments on Amazon
Mechanical Turk. Judgment and Decision Making, 5(5).

96

	
  
Petrie, T. A., Greenleaf, C., Reel, J., & Carter, J. (2008). Prevalence of eating disorders and
disordered eating behaviors among male collegiate athletes. Psychology of Men &
Masculinity, 9(4), 267–277.
Ponnet, K., Wouters, E., Walrave, M., Heirman, W., & Van Hal, G. (2015). Predicting
students’ intention to use stimulants for academic performance enhancement.
Substance Use & Misuse, 50(3), 275-282. doi: 10.3109/10826084.2014.952446
Pope, H. G., Gruber, A. J., Choi, P., Olivardia, R., & Phillips, K. A. (1997). Muscle
dysmorphia: An underrecognized form of body dysmorphic disorder. Psychosomatics,
38(6), 548–557.
Pursey, K., Burrows, T. L., Stanwell, P., & Collins, C. E. (2014). How accurate is web-based
self-reported height, weight, and body mass index in young adults? Journal of
Medical Internet Research, 16(1): e4. doi: 10.2196/jmir.2909
Rabiner, D. L., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., McCabe, S. E., &
Swartzwelder, H. S. (2009). The misuse and diversion of prescribed ADHD
medications by college students. Journal of Attention Disorders, 13(2), 144-153. doi:
10.1177/1087054708320414
Rawana, J. S., Morgan, A. S., Nguyen, H., & Craig, S. G. (2010). The relation between
eating- and weight-related disturbances and depression in adolescence: A review.
Clinical Child and Family Psychology Review, 13(3), 213-230.
Reese, E. D., Pollert, G. A., & Veilleux, J. C. (2016). Self-regulatory predictors of eating
disorder symptoms: Understanding the contributions of action control and willpower
beliefs. Eating Behaviors, 20, 64-69. http://dx.doi.org/10.1016/j.eatbeh.2015.11.005
Ritalin LA. (2014). Retrieved from http://www.pdr.net/drug-summary/ritalinla?druglabelid=1003&id=3820
Rose, J. S., Vaewsorn, A., Rosselli-Navarra, F., Wilson, G. T., & Weissman, R. S. (2013).
Test-retest reliability of the eating disorder examination-questionnaire (EDE-Q) in a
college sample. Journal of Eating Disorders, 1(42). doi: 10.1186/2050-2974-1-42
Schepis, T., & Hakes, J. K. (2011). Non-medical prescription use increases the risk for the
onset and recurrence of psychopathology: Results from the national epidemiological
survey on alcohol and related conditions. Addiction, 106, 2146–2155.

97

	
  
Schepis, T., & Krishnan-Sarin, S. (2008). Characterizing adolescent prescription misusers: A
population based study. Journal of the American Academy of Child and Adolescent
Psychiatry, 47(7), 745–754.
Schmidt, W. C. (2007). Technical considerations when implementing online research. In A.
Joinson, K. McKenna, T. Postmes & U.-D. Reips (Eds.), The Oxford handbook of
internet psychology (The Oxford handbook of internet psychology ed., pp. 461-472).
Oxford: Oxford University Press.
Schreiber, L. R., Odlaug, B. L., & Grant, J. E. (2013). The overlap between binge eating
disorder and substance use disorders: Diagnosis and neurobiology. Journal of
Behavioral Addictions, 2(4), 191-198. http://dx.doi.org/10.1556/JBA.2.2013.015
Shapiro, D. N., Chandler, J., & Mueller, P. A. (2013). Using Mechanical Turk to Study
Clinical Populations. Clinical Psychological Science, 1(2), 213-220. doi:
10.1177/2167702612469015
Srigley, G. L. (2013). The Theory of Planned Behavior and nonmedical use of prescription
drugs. (Master's thesis), North Carolina State University. Retrieved from
http://repository.lib.ncsu.edu/ir/bitstream/1840.16/9168/1/etd.pdf
Substance Abuse and Mental Health Services Administration, Results from the 2012 National
Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and
Mental Health Services Administration, 2013.
Substance Abuse and Mental Health Services Administration. (January 24, 2013). The
DAWN Report: Emergency Department Visits Involving Attention
Deficit/Hyperactivity Disorder Stimulant Medications. Rockville, MD: Center for
Behavioral Health Statistics and Quality.
Substance Abuse and Mental Health Services Administration, Results from the 2013 National
Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and
Mental Health Services Administration, 2014.
Teter, C. J., McCabe, S. E., LaGrange, K., Cranford, J. A., & Boyd, C. J. (2006). Illicit use of
specific prescription stimulants among college students. Pharmacotherapy, 26(10),
1501-1510.

98

	
  
Thompson, J. K., van den Berg, P., Roehrig, M., Guarda, A. S., & Heinberg, L. J. (2004).
The sociocultural attitudes towards appearance scale-3 (SATAQ-3): development and
validation. International Journal of Eating Disorders, 35(3), 293-304. doi:
10.1002/eat.10257
Tucker, L. R., & Lewis, C. (1973). A reliability coefficient for maximum likelihood factor
analysis. Psychometrika, 38, 1-10.
Tylka, T. L. (2012). Positive psychology perspectives on body image. In T. F. Cash (Ed.),
Encyclopedia of body image and human appearance (Vol. 2) (pp. 657–663). Oxford:
Academic Press. http://dx.doi.org/10.1016/B978-0-12-384925-0.00104-8
U.S. Census Bureau. (2014a). Annual estimates of the resident population: April 1, 2010 to
July 1, 2014.Retrieved from
http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkm
k
U.S. Census Bureau. (2014b). United States QuickFacts. Retrieved from
http://www.census.gov/quickfacts/table/PST045215/00
Van Dam, N. T., & Earleywine, M. (2011). Validation of the Center for Epidemiologic
Studies Depression Scale--Revised (CESD-R): pragmatic depression assessment in
the general population. Psychiatry Research, 186(1), 128-132.
Vander Wal, J. S. (2012). The relationship between body mass index and unhealthy weight
control behaviors among adolescents: The role of family and peer social support.
Economics & Human Biology, 10(4), 395-404.
Van De Ven, M. O., Engels, R. C., Otten, R., & Van Den Eijnden, R. J. (2007). A
longitudinal test of the theory of planned behavior predicting smoking onset among
asthmatic and non-asthmatic adolescents. Journal of Behavioral Medicine, 30(5),
435-445. doi: 10.1007/s10865-007-9119-2
Vyvanse. (2014). Retrieved from http://www.pdr.net/drugsummary/vyvanse?druglabelid=538&id=2611
Wilens, T. E, Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R.,… Fusillo, S.
(2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic
review of the literature. Journal of the American Academy of Child & Adolescent
Psychiatry, 47(1), 21-31.
99

	
  
Woolsey, C. L., Williams, R. D., Jacobson, B. H., Housman, J. M., McDonald, J. D., Swartz,
J. H.,… Davidson, R. T. (2015). Increased energy drink use as a predictor of illicit
prescription stimulant use. Substance Abuse, 36(4), 413-419. doi:
10.1080/08897077.2014.969470
Wu, L. T., Pilowsky, D. J., Schlenger, W. E., & Galvin, D. M. (2007). Misuse of
methamphetamine and prescription stimulants among youths and young adults in the
community. Drug and Alcohol Dependence, 89(2-3), 195-205. doi:
10.1016/j.drugalcdep.2006.12.020
Young, A. M., Glover, N., & Havens, J. R. (2012). Nonmedical use of prescription
medications among adolescents in the United States: A systematic review. Journal of
Adolescent Health, 51(1), 6–17.
Zachor, D. A., Roberts, A. W., Hodgens, J. B., Isaacs, J. S., & Merrick, J. (2006). Effects of
long-term psychostimulant medication on growth of children with ADHD. Research
in Developmental Disabilities, 27(2), 162-174. doi: 10.1016/j.ridd.2004.12.004
Zullig, K. J., & Divin, A. L. (2012). The association between non-medical prescription drug
use, depressive symptoms, and suicidality among college students. Addictive
Behaviors, 37(8), 890-899. doi: 10.1016/j.addbeh.2012.02.008

100

	
  

Appendix A
Demographics

1. Which best describes you?
Male
Female
Transgender
2. Which best describes you?
White
African-American
Hispanic/Latino
Asian-American
Native American
Other_________
3. How old are you? __________
4. How tall are you (in inches)? _________
5. How much do you weigh (in pounds)? __________
6. Which of the following best describes your highest achieved education level?
Less than high school
High school/GED
College or University/1st year completed
College or University/2nd year completed
College or University/3rd year completed
College or University/4th year completed
College or University/5th or higher year completed
2-year college degree (Associates)
4-year college degree (BA, BS)
Master’s Degree
Doctoral Degree
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Professional Degree (MD, JD)
7. What was your total household income last year?
$0-25,999
$26,000-$51,999
$52,000-74,999
more than $75,000
don’t know/decline to say
8. Are you currently enrolled at a college or university?
Yes
No
9. Have you ever been diagnosed with Attention deficit hyperactivity disorder (ADHD)?
Yes
No
10. Have you ever been prescribed a prescription stimulant medication by a doctor to treat
ADHD (e.g., Adderall, Ritalin, Vyvanse)?
Yes
No
11. Are you currently being prescribed a prescription stimulant medication by a doctor to
treat ADHD (e.g., Adderall, Ritalin, Vyvanse)?
Yes
No
12a. Have you ever been prescribed a medication by a doctor for weight loss?
Yes
No
12b. If yes, please list the medication(s). _____________________
13. Are you currently being prescribed a medication by a doctor for weight loss?
Yes
No
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14. Are you currently trying to:
a) Lose weight
b) Stay the same weight
c) Gain weight
d) I am not trying to do anything about my weight
15. How often have you gone on a diet during the last year? By “diet” we mean changing the
way you eat so you can lose weight.
a) never
b) 1-4 times
c) 5-10 times
d) more than 10 times
e) I am always dieting
16. Have you ever tried to lose weight?
Yes
No
17. In which state do you live? _____________________
18. Which best describes your place of residence?
Urban
Rural
19. Who is the president of the United States?* _____________________
*(Quality assurance question #1)
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NMUPS Frequency
1a. On how many occasions (if any) in your lifetime have you used a prescription stimulant
normally used to treat ADHD (e.g., Adderall, Ritalin, Concerta, Vyvanse), NOT prescribed
to you?
1)  
2)  
3)  
4)  
5)  
6)  
7)  

no occasions
1-2 occasions
3-5 occasions
6-9 occasions
10-19 occasions
20-39 occasions
40 or more occasions

1b. On how many occasions (if any) in the past 12 months have you used a prescription
stimulant normally used to treat ADHD (e.g., Adderall, Ritalin, Concerta, Vyvanse), NOT
prescribed to you?
1)  
2)  
3)  
4)  
5)  
6)  
7)  

no occasions
1-2 occasions
3-5 occasions
6-9 occasions
10-19 occasions
20-39 occasions
40 or more occasions
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Motivations for NMUPS (Lifetime)
Why have you ever used
prescription stimulants not
prescribed to you?
1. To get high
2. Pain relief
3. Weight loss/appetite
suppression
4. Increased energy
5. Sexual stimulant
6. Study aid
7. Coping with a difficult
problem
8. To forget my worries
9. To fit in and not be
excluded
10. To feel more selfconfident
11. To reduce anxiety
12. To increase
concentration
13. To try something new
14. Because it helps increase
my alertness
15. Because it counteracts
the effects of other drugs
16. Because of
experimentation
17. Because it’s safer than
street drugs
18. Because I’m addicted

Yes

No

1
1
1

2
2
2

1
1
1
1

2
2
2
2

1
1

2
2

1

2

1
1

2
2

1
1

2
2

1

2

1

2

1

2

1

2

Please fill in any additional reasons you have ever used a prescription stimulant medication
not prescribed to you. _______________
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Motivations for NMUPS (Past Year)
In the past year, why have
you used prescription
stimulants not prescribed to
you?
1. To get high
2. Pain relief
3. Weight loss/appetite
suppression
4. Increased energy
5. Sexual stimulant
6. Study aid
7. Coping with a difficult
problem
8. To forget my worries
9. To fit in and not be
excluded
10. To feel more selfconfident
11. To reduce anxiety
12. To increase
concentration
13. To try something new
14. Because it helps increase
my alertness
15. Because it counteracts
the effects of other drugs
16. Because of
experimentation
17. Because it’s safer than
street drugs
18. Because I’m addicted

Yes

No

1
1
1

2
2
2

1
1
1
1

2
2
2
2

1
1

2
2

1

2

1
1

2
2

1
1

2
2

1

2

1

2

1

2

1

2

Please fill in any additional reasons you have used a prescription stimulant medication not
prescribed to you within the past year. _______________
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NMUPS Age of Onset
1. How old were you when you started using a prescription stimulant without a doctor’s
orders? If you can’t remember, please make your best guess.
_______________
2. How old were you when you started using a prescription stimulant without a doctor’s
orders specifically for the purpose of weight loss/appetite suppressive effects? If you can’t
remember, please make your best guess.
_______________
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Decision to Engage in NMUPS for Weight Loss
1. What made you decide to try a prescription stimulant without a doctor’s orders specifically
for the purpose of weight loss/appetite suppressive effects?
a)  
b)  
c)  
d)  

You knew someone else who was doing it
You heard about the idea from the media (e.g., TV, radio, Internet)
Someone else gave you their ADHD medication specifically for that purpose
Other ________
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Medication Source for Those Who Have Engaged in NMUPS
1. If you have ever used a prescription stimulant medication not prescribed to you, who did
you get it from?
a) Friends
b) Family
c) Internet
d) Stranger
e) Other ________________
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Perceived Effectiveness of NMUPS for Weight Loss
1. How effective has using a prescription stimulant without a doctor’s orders been in helping
you lose weight?
1) Not at all effective
2) Mildly effective
3) Somewhat effective
4) Very effective
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Negative Consequences Associated With NMUPS
1. How often (if ever) have you experienced the following as a result of using a prescription
stimulant without a doctor’s orders?
Never Lifetime
1-2
3-5
6-9
but not occasions occasions occasions
past
in past
in past
in past
year
year
year
year
1. Said or done
something
embarrassing
2. Felt guilty or
ashamed
3. Performed
poorly at school
or work
4. Felt bad
physically
5. Spent too
much money or
lost a lot of
money
6. Missed school,
work, or
activities with
friends
7. Done
impulsive things
you later
regretted
8. Spent a
significant
amount of time
thinking about,
looking for, or
using
9. Taken drugs
in larger
amounts or over
longer period of
time than you
planned

10-19
occasions
in past
year

20-39
occasions
in past
year

40+ times
in past year

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7
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Never Lifetime
1-2
3-5
6-9
but not occasions occasions occasions
past
in past
in past
in past
year
year
year
year

10-19
occasions
in past
year

20-39
occasions
in past
year

40+ times
in past year

10. Failed to do
what was
expected of you
11. Need more
drugs to get the
same effect or
don’t get the
same effect with
the usual amount
12. Lost interest
in activities or
hobbies

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

13. Been
unhappy because
of my stimulant
use
14. Lost weight
or not eaten
properly because
of my stimulant
use
15. Gotten into a
physical fight
16. Lost a close
relationship
17. My
personality has
changed for the
worse
18. Take more to
avoid or reduce
withdrawal
19. Gotten into
legal trouble or
arrested

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7
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Never Lifetime
1-2
3-5
6-9
but not occasions occasions occasions
past
in past
in past
in past
year
year
year
year
20. Been
suspended,
expelled from
school, or fired
from work
21. Enjoyed
using drugs
22. While using
stimulants I said
harsh or cruel
things to
someone
23. Wanted or
tried to limit, cut
down, or stop
24. Continued to
use despite
psychological or
physical
consequence
25. Needed
medical
treatment

10-19
occasions
in past
year

20-39
occasions
in past
year

40+ times
in past year

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7
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Medication Knowledge
1.   Please indicate the extent to which you agree/disagree with the following statement: I
consider myself to be knowledgeable about the side effects associated with the use of
stimulant medication normally used to treat ADHD (e.g., Adderall, Ritalin, Vyvanse).
1. Strongly Disagree
2. Disagree
3. Neither
4. Agree
5. Strongly Agree
2.   Have you ever been exposed to information about the side effects associated with the
use of stimulant medication normally used to treat ADHD (e.g., Adderall, Ritalin,
Vyvanse)? (Please indicate all sources that apply)
No I have not
Internet
Magazine
Healthcare facility pamphlet
In class
Information session
Other students/friends
Parents
Television
Books
Other
3.   Individuals taking stimulant medication may experience the following short term or
long term side effects and/or adverse consequences (Please answer “Yes,” for those
that are side effects, “No” for those that are not side effects, and “Don’t know” if you
do not know the answer):
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Nighttime wakefulness (insomnia)
Increase in blood pressure
Sore throat
Increase in heart rate
Reductions in appetite
Adverse psychiatric problems
Sudden death
Nausea
Cardiovascular adverse reactions
Dry mouth
Headache
Abdominal pain
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No
No
No
No
No
No
No
No
No
No
No
No
No

Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know

	
  
Vomiting
Agitation
Anxiety
Dizziness
Tachycardia (excessively rapid heartbeat)
Diarrhea

Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No

Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know

4.   Below are contraindications (specific situations in which a drug should not be used
because it may be harmful) listed for stimulant medications that may or may not be
true (Please answer “True,” for those that are contraindications, “False” for those that
are not contraindications, and “Don’t know” if you do not know the answer):
History of drug abuse
Hyperthyroidism
Glaucoma
Serious cardiac (heart) problems
During or within 14 days following MAOI
(antidepressant medication) use
Crohn’s disease
Migraines
Influenza

True
True
True
True
True
True

False
False
False
False
False
False

Don’t know
Don’t know
Don’t know
Don’t know
Don’t know
Don’t know

True
True
True

False
False
False

Don’t know
Don’t know
Don’t know

5.   What would you want your last meal to be?* ________________________
*(Quality assurance question #2)
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Attitudes (TPB)
Please rate the extent to which you agree or disagree with each of the following questions
(Choose one): strongly disagree, moderately disagree, somewhat disagree, no opinion,
somewhat agree, moderately agree, strongly agree.
1.   It is ethical for people without diagnosed ADHD to use stimulant medication for any
reason.
2.   It is ethical for people diagnosed with ADHD to use stimulant medication in excess or
for purposes other than prescribed by a physician.
3.   It is ethical for people with diagnosed ADHD to use stimulant medication to lose
weight/control appetite.
4.   It is ethical for people without diagnosed ADHD to use stimulant medication to lose
weight/control appetite.
5.   I believe it is safe for people to use stimulant medication in excess or for purposes
other than prescribed by a physician.
6.   I am concerned that taking stimulant medication in excess or for purposes other than
prescribed by a physician will adversely affect a person’s health.
7.   I am concerned that taking stimulant medication to lose weight/control appetite will
adversely affect a person’s health.
8.   I feel that the benefits of using a prescription stimulant medication without a doctor’s
orders for any reason outweigh the potential risks.
9.   I feel that the benefits of someone misusing their own prescription stimulant
medication for any reason outweigh the potential risks.
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Subjective Norms (TPB)
Please rate the extent to which you agree or disagree with each of the following questions
(Choose one): strongly disagree, moderately disagree, somewhat disagree, no opinion,
somewhat agree, moderately agree, strongly agree.
1.   It is socially acceptable for people without diagnosed ADHD to use stimulant
medication for any reason.
2.   It is socially acceptable for people diagnosed with ADHD to use stimulant medication
in excess or for purposes other than prescribed by a physician.
3.   My friends/family/significant other believe that it is ok for people without diagnosed
ADHD to use stimulant medication for any reason.
4.   My friends/family/significant other believe that it is ok for people diagnosed with
ADHD to use medication in excess or for purposes other than prescribed.
5.   I know at least one person (e.g., family member/friend/significant other) who uses
stimulant medications for the purpose of weight loss/appetite suppression without a
doctor’s prescription.
6.   I know at least one person (e.g., family member/friend/significant other) who misuses
his/her own stimulant medication for the purpose of weight loss/appetite suppression.
7.   I value my friends’/ family’s/significant other’s opinion on whether or not it is ok for
people with a prescription to use the stimulant medication in excess or for purposes
other than prescribed.
8.   I value my friends’/ family’s/significant other’s opinion on whether or not it is ok for
people without a prescription to use the stimulant medication for any reason.
9.   I believe the use of stimulant medication by people without diagnosed ADHD, is
common.
10.  I believe the use of stimulant medication by people diagnosed with ADHD in excess
or for purposes other than prescribed, is common.
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Perceived Behavioral Control (TPB)
Please rate the extent to which you agree or disagree with each of the following questions
(Choose one): strongly disagree, moderately disagree, somewhat disagree, no opinion,
somewhat agree, moderately agree, strongly agree.
1.   I feel I do not need stimulant medication to help me lose weight/control my appetite.
2.   I am confident that I could get a stimulant medication from someone if I wanted to.
3.   I feel I could lose weight successfully without the help of a stimulant medication.
4.   I know people that would give/sell me a prescription stimulant medication if I wanted
it.
Please check the number four below:*
1

2

3

4

5

6

*(Quality assurance question #3)
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Disordered Eating Attitudes/Behaviors (Past 28 Days; EDE-Q)
Instructions: The following questions are concerned with the past four weeks (28 days) only.
Please read each question carefully. Please answer all the questions.
Questions 1 to 12: Please choose the appropriate response. Remember that questions
only refer to the past four weeks (28 days) only.
On how many of the past 28 days...
1. Have you been deliberately trying to limit the amount of food you eat to influence your
shape or weight (whether or not you have succeeded)?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

2. Have you gone for long periods of time (8 waking hours or more) without eating anything
at all in order to influence your shape or weight?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

3. Have you tried to exclude from your diet any foods that you like in order to influence your
shape or weight (whether or not you have succeeded)?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

4. Have you tried to follow definite rules regarding your eating (for example, a calorie limit)
in order to influence your shape or weight (whether or not you have succeeded)?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

5. Have you had a definite desire to have an empty stomach with the aim of influencing your
shape or weight?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

5
23-27 days

6
Every day

6. Have you had a definite desire to have a totally flat stomach?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days
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7. Has thinking about food, eating, or calories made it very difficult to concentrate on things
you are interested in (for example, working, following a conversation, or reading)?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

8. Has thinking about shape or weight made it very difficult to concentrate on things you are
interested in (for example, working, following a conversation, or reading)?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

5
23-27 days

6
Every day

9. Have you had a definite fear of losing control over eating?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

10. Have you had a definite fear that you might gain weight?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

4
16-22 days

5
23-27 days

6
Every day

11. Have you felt fat?
0
No days

1
1-5 days

12. Have you had a strong desire to lose weight?
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

Questions 13-18: Please fill in the appropriate number on the line below. Remember
that the questions only refer to the past four weeks (28 days).
Over the past four weeks (28 days)...
13. Over the past 28 days, how many times have you eaten what other people would regard
as an unusually large amount of food (given the circumstances)?
_____________
14. ... On how many of these times did you have a sense of having lost control over your
eating (at the time that you were eating)?
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_____________
15. Over the past 28 days, on how many DAYS have such episodes of overeating occurred
(i.e., you have eaten an unusually large amount of food and have had a sense of loss of
control at the time)?
_____________
16. Over the past 28 days, how many times have you made yourself sick (vomit) as a means
of controlling your shape or weight?
_____________
17. Over the past 28 days, how many times have you taken laxatives as a means of
controlling your shape or weight?
_____________
18. Over the past 28 days, how many times have you exercised in a “driven” or “compulsive”
way as a means of controlling your weight, shape or amount of fat, or to burn off calories?
_____________
Questions 19 to 21: Please choose the appropriate response. Please note that for these
questions the term “binge eating” means eating what others would regard as an
unusually large amount of food for the circumstances, accompanied by a sense of
having lost control over eating.
19. Over the past 28 days, on how many days have you eaten in secret (i.e., furtively)?
... Do not count episodes of binge eating
0
No days

1
1-5 days

2
6-12 days

3
13-15 days

4
16-22 days

5
23-27 days

6
Every day

20. On what proportion of the times that you have eaten have you felt guilty (felt that you’ve
done wrong) because of its effect on your shape or weight?
... Do not count episodes of binge eating
0
None of
the times

1
A few of
the times

2
Less than
half

3
Half of the
times

4
More than
half

5
6
Most of the Every time
time

21. Over the past 28 days, how concerned have you been about other people seeing you eat?
... Do not count episodes of binge eating
0
Not at all

1

2
Slightly

3

4
Moderately
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Questions 22 to 28: Please choose the appropriate response. Remember that the
questions only refer to the past four weeks (28 days).
Over the past 28 days...
22. Has your weight influenced how you think about (judge) yourself as a person?
0
Not at all

1

2
Slightly

3

4
Moderately

5

6
Markedly

23. Has your shape influenced how you think about (judge) yourself as a person?
0
Not at all

1

2
Slightly

3

4
Moderately

5

6
Markedly

24. How much would it have upset you if you had been asked to weigh yourself once a week
(no more, or less, often) for the next four weeks?
0
Not at all

1

2
Slightly

3

4
Moderately

5

6
Markedly

4
Moderately

5

6
Markedly

4
Moderately

5

6
Markedly

25. How dissatisfied have you been with your weight?
0
Not at all

1

2
Slightly

3

26. How dissatisfied have you been with your shape?
0
Not at all

1

2
Slightly

3

27. How uncomfortable have you felt seeing your body (for example, seeing your shape in
the mirror, in a shop window reflection, while undressing or taking a bath or shower)?
0
Not at all

1

2
Slightly

3

4
Moderately

5

6
Markedly

28. How uncomfortable have you felt about others seeing your shape or figure (for example,
in communal changing rooms, when swimming, or wearing tight clothes)?
0
Not at all

1

2
Slightly

3

4
Moderately
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Healthy and Unhealthy Weight Loss Behaviors (Past 12 Months)
1. How often have you done each of the following things in order to lose weight or keep from
gaining weight during the past year?

Fasted
Ate very little food
Exercise
Took diet pills
Ate more fruits and vegetables
Ate less high-fat foods
Used diuretics (water pills)
Ate less sweets
Used food substitute (powder/special
drink)
Drank less soda pop (not including diet
soda)
Skipped meals
Smoked more cigarettes
Watched my portion sizes (serving sizes)
Followed a high protein/low
carbohydrate diet (e.g., Atkins or other)
Drank energy drinks (e.g., Red Bull,
Monster)
While watching the television, how often
have you ever had a fatal heart attack?*
*(Quality assurance question #4)
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Never

Rarely

Sometimes

1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3

On a
regular
basis
4
4
4
4
4
4
4
4
4

1

2

3

4

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

1

2

3

4

1

2

3

4

	
  
Body Dissatisfaction (MBSRQ; Appearance Evaluation Subscale)
Please read each of the
following items carefully and
indicate the number that best
reflects your agreement with
the statement.
1. My body is sexually
appealing.
2. I like my looks just the way
they are.
3. Most people would consider
me good-looking.
4. I like the way I look without
my clothes on.
5. I like the way my clothes fit
me.
6. I dislike my physique.
7. I am physically unattractive.

Definitely
Disagree

Mostly
Disagree

Neither
Agree Nor
Disagree

Mostly
Agree

Definitely
Agree

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1
1

2
2

3
3

4
4

5
5
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Media Influence on Body Image (SATAQ-3; Pressures Subscale)
Please read each of the following
items carefully and indicate the
number that best reflects your
agreement with the statement.
1. I've felt pressure from TV or
magazines to lose weight.
2. I do not feel pressure from TV or
magazines to look pretty (or
muscular).
3. I've felt pressure from TV and
magazines to be thin (or muscular).
4. I've felt pressure from TV or
magazines to have a perfect body.
5. I've felt pressure from TV or
magazines to diet.
6. I've felt pressure from TV or
magazines to exercise.
7. I've felt pressure from TV or
magazines to change my
appearance.

Definitely
Disagree

Mostly
Disagree

Neither
Agree
Nor
Disagree

Mostly
Agree

Definitely
Agree

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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Depressive Symptomatology (CESD-R)
Below is a list of the ways you might
Not at all
have felt or behaved. Please check the or less than
boxes to tell me how often you have
1 day
felt this way in the past week or so.
1. My appetite was poor.
0
2. I could not shake off the blues.
0
3. I had trouble keeping my mind on
0
what I was doing.
4. I felt depressed.
0
5. My sleep was restless.
0
6. I felt sad.
0
7. I could not get going.
0
8. Nothing made me happy.
0
9. I felt like a bad person.
0
10. I lost interest in my usual
0
activities.
11. I slept much more than usual.
0
12. I felt like I was moving too slowly.
0
13. I felt fidgety.
0
14. I wished I were dead.
0
15. I wanted to hurt myself.
0
16. I was tired all the time.
0
17. I did not like myself.
0
18. I lost a lot of weight without trying
0
to.
19. I had a lot of trouble getting to
0
sleep.
20. I could not focus on the important
0
things.
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1 - 2 days

3 - 4 days

5 - 7 days

Nearly every
day for 2
weeks

1
1
1

2
2
2

3
3
3

4
4
4

1
1
1
1
1
1
1

2
2
2
2
2
2
2

3
3
3
3
3
3
3

4
4
4
4
4
4
4

1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4

1

2

3

4

1

2

3

4

	
  
Other Substance Use
Please indicate on
how many occasions
(if any) you have
used the following in
the past year:
Energy Drinks
Tobacco products
(Cigarettes, water
pipe, cigars,
smokeless
tobacco)
Alcohol (beer, wine,
liquor)
Marijuana (pot,
weed, hashish, hash
oil)
Cocaine (crack,
rock, freebase,
powder)
Methamphetamine
(crystal meth, ice,
crank)
Other
amphetamines
(bennies)
Anabolic steroids
(Testosterone)
Opiates (heroin,
smack)
MDMA (Ecstasy)

No
occasions

1-2
occasions

3-5
occasions

6-9
occasions

10-19
occasions

20-39
occasions

40 or more
occasions

1
1

2
2

3
3

4
4

5
5

6
6

7
7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

If you have used any other recreational drugs in the past year please list them.
_________________
1. What do you think the purpose of this study was? (Please make your best guess.)*
_______________________
*(Quality assurance question #5)
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